CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: cephalosporin
Accession: CHEBI:23066
browse the term
Definition: A class of beta-lactam antibiotics differing from the penicillins in having a 6-membered, rather than a 5-membered, side ring. Although cephalosporins are among the most commonly used antibiotics in the treatment of routine infections, and their use is increasing over time, they can cause a range of hypersensitivity reactions, from mild, delayed-onset cutaneous reactions to life-threatening anaphylaxis in patients with immunoglobulin E (IgE)-mediated allergy.
Synonyms: related_synonym: Formula=C7H5NO3SR2; SMILES=[H][C@]12SCC([*])=C(N1C(=O)[C@H]2[*])C(O)=O; cephalosphorin; cephalosphorins; cephalosporins
alt_id: CHEBI:3538
xref: KEGG:C00875; PMID:10069359; PMID:11936371; PMID:12833570; PMID:24269048; PMID:3320614; PMID:6762896; PMID:8426246; Wikipedia:Cephalosporin
G
Ampd3
adenosine monophosphate deaminase 3
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of AMPD3 mRNA
CTD
PMID:24211530
NCBI chr 1:175,585,301...175,630,479
Ensembl chr 1:175,586,097...175,630,467
G
Fth1
ferritin heavy chain 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of FTH1 mRNA
CTD
PMID:24211530
NCBI chr 1:226,030,940...226,033,228
Ensembl chr 1:226,030,938...226,033,228
G
Ftl1
ferritin light chain 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of FTL mRNA
CTD
PMID:24211530
NCBI chr 1:101,448,190...101,450,034
Ensembl chr 1:101,448,346...101,449,829
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of GCLM mRNA
CTD
PMID:24211530
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
G
Hmox1
heme oxygenase 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of HMOX1 mRNA
CTD
PMID:24211530
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of MYC mRNA
CTD
PMID:24211530
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of NQO1 mRNA
CTD
PMID:24211530
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Sel1l3
SEL1L family member 3
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of SEL1L3 mRNA
CTD
PMID:24211530
NCBI chr14:60,122,968...60,229,565
Ensembl chr14:60,123,169...60,229,734
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of SLC7A11 mRNA
CTD
PMID:24211530
NCBI chr 2:139,453,774...139,528,479
Ensembl chr 2:139,453,774...139,528,162
G
Sqstm1
sequestosome 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of SQSTM1 mRNA
CTD
PMID:24211530
NCBI chr10:35,704,728...35,716,316
Ensembl chr10:35,704,730...35,716,294
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
ISO
7-aminocephalosporanic acid results in decreased expression of SYNE2 mRNA
CTD
PMID:24211530
NCBI chr 6:98,884,269...99,153,551
G
Tnnt2
troponin T2, cardiac type
decreases expression
ISO
7-aminocephalosporanic acid results in decreased expression of TNNT2 mRNA
CTD
PMID:24211530
NCBI chr13:52,662,974...52,680,992
Ensembl chr13:52,662,996...52,680,990
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of TXNRD1 mRNA
CTD
PMID:24211530
NCBI chr 7:26,946,124...26,984,400
Ensembl chr 7:26,946,125...26,984,400
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
ISO
Cefaclor inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Cefaclor results in decreased activity of ABCB11 protein
CTD
PMID:24014644
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
increases expression
ISO
Cefaclor results in increased expression of CYP3A4 mRNA; Cefaclor results in increased expression of CYP3A4 protein
CTD
PMID:18505790
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
ISO
Cefaclor inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of Cefaclor Cefaclor inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
increases expression
ISO
Cefadroxil results in increased expression of CYP3A4 mRNA; Cefadroxil results in increased expression of CYP3A4 protein
CTD
PMID:18505790
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
G
Aadac
arylacetamide deacetylase
increases expression
EXP
Cephaloridine results in increased expression of AADAC mRNA
CTD
PMID:18500788
NCBI chr 2:150,146,234...150,157,480
Ensembl chr 2:150,146,234...150,157,480
G
Aass
aminoadipate-semialdehyde synthase
decreases expression
EXP
Cephaloridine results in decreased expression of AASS mRNA
CTD
PMID:18500788
NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328
G
Abcb1b
ATP-binding cassette, subfamily B (MDR/TAP), member 1B
increases expression
EXP
Cephaloridine results in increased expression of ABCB1B mRNA
CTD
PMID:18500788
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
EXP
Cephaloridine results in increased expression of ABCC2 mRNA
CTD
PMID:18500788
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
G
Acmsd
aminocarboxymuconate semialdehyde decarboxylase
decreases expression
EXP
Cephaloridine results in decreased expression of ACMSD mRNA
CTD
PMID:18500788
NCBI chr13:44,424,689...44,468,734
Ensembl chr13:44,424,689...44,468,734
G
Acot9
acyl-CoA thioesterase 9
increases expression
EXP
Cephaloridine results in increased expression of ACOT9 mRNA
CTD
PMID:18500788
NCBI chr X:43,543,069...43,592,200
Ensembl chr X:43,543,070...43,592,200
G
Acsm5
acyl-CoA synthetase medium-chain family member 5
decreases expression
EXP
Cephaloridine results in decreased expression of ACSM5 mRNA
CTD
PMID:18500788
NCBI chr 1:189,240,955...189,270,422
Ensembl chr 1:189,233,141...189,272,172
G
Adam8
ADAM metallopeptidase domain 8
decreases expression
EXP
Cephaloridine results in decreased expression of ADAM8 mRNA
CTD
PMID:18500788
NCBI chr 1:212,317,510...212,332,895
Ensembl chr 1:212,317,848...212,330,349
G
Adgre1
adhesion G protein-coupled receptor E1
increases expression
EXP
Cephaloridine results in increased expression of ADGRE1 mRNA
CTD
PMID:18500788
NCBI chr 9:9,431,888...9,585,883
Ensembl chr 9:9,431,860...9,585,865
G
Adora2a
adenosine A2a receptor
increases expression
EXP
Cephaloridine results in increased expression of ADORA2A mRNA
CTD
PMID:18500788
NCBI chr20:14,265,251...14,282,873
Ensembl chr20:14,265,252...14,282,873
G
Adra1d
adrenoceptor alpha 1D
increases expression
EXP
Cephaloridine results in increased expression of ADRA1D mRNA
CTD
PMID:18500788
NCBI chr 3:124,129,558...124,145,566
Ensembl chr 3:124,129,558...124,145,566
G
Aftph
aftiphilin
decreases expression
EXP
Cephaloridine results in decreased expression of AFTPH mRNA
CTD
PMID:18500788
NCBI chr14:104,921,633...104,975,763
Ensembl chr14:104,922,282...104,960,141
G
Akr1b1
aldo-keto reductase family 1 member B
increases expression
EXP
Cephaloridine results in increased expression of AKR1B1 mRNA
CTD
PMID:18172885
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
G
Akr1b8
aldo-keto reductase family 1, member B8
increases expression
EXP
Cephaloridine results in increased expression of AKR1B8 mRNA
CTD
PMID:18500788
NCBI chr 4:61,772,064...61,784,637
Ensembl chr 4:61,771,970...61,828,657
G
Akr1d1
aldo-keto reductase family 1, member D1
increases expression
EXP
Cephaloridine results in increased expression of AKR1D1 mRNA
CTD
PMID:18172885
NCBI chr 4:65,110,706...65,143,930
Ensembl chr 4:65,110,746...65,143,941
G
Alas1
5'-aminolevulinate synthase 1
increases expression
EXP
Cephaloridine results in increased expression of ALAS1 mRNA
CTD
PMID:18500788
NCBI chr 8:114,927,704...114,941,038
Ensembl chr 8:114,927,722...114,940,177
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
increases expression
EXP
Cephaloridine results in increased expression of ALDH3A1 mRNA
CTD
PMID:18500788
NCBI chr10:47,490,168...47,499,855
Ensembl chr10:47,490,153...47,499,876
G
Aldh3b1
aldehyde dehydrogenase 3 family, member B1
increases expression
EXP
Cephaloridine results in increased expression of ALDH3B1 mRNA
CTD
PMID:18500788
NCBI chr 1:219,145,457...219,181,536
Ensembl chr 1:219,145,459...219,186,860
G
Aldoa
aldolase, fructose-bisphosphate A
affects expression
EXP
Cephaloridine affects the expression of ALDOA mRNA
CTD
PMID:18172885
NCBI chr 1:198,228,387...198,233,988
Ensembl chr 1:198,228,387...198,233,588
G
Amer2
APC membrane recruitment protein 2
decreases expression
EXP
Cephaloridine results in decreased expression of AMER2 mRNA
CTD
PMID:18500788
NCBI chr15:40,663,183...40,667,705
Ensembl chr15:40,665,041...40,667,173
G
Amigo2
adhesion molecule with Ig like domain 2
increases expression
EXP
Cephaloridine results in increased expression of AMIGO2 mRNA
CTD
PMID:18500788
NCBI chr 7:138,704,124...138,707,221
Ensembl chr 7:138,704,126...138,707,221
G
Ampd1
adenosine monophosphate deaminase 1
increases expression
EXP
Cephaloridine results in increased expression of AMPD1 mRNA
CTD
PMID:18500788
NCBI chr 2:205,568,934...205,589,961
Ensembl chr 2:205,568,935...205,590,021
G
Ampd3
adenosine monophosphate deaminase 3
increases expression
EXP
Cephaloridine results in increased expression of AMPD3 mRNA
CTD
PMID:18500788
NCBI chr 1:175,585,301...175,630,479
Ensembl chr 1:175,586,097...175,630,467
G
Angptl4
angiopoietin-like 4
increases expression
EXP
Cephaloridine results in increased expression of ANGPTL4 mRNA
CTD
PMID:18500788
NCBI chr 7:18,627,814...18,634,043
Ensembl chr 7:18,627,808...18,634,079
G
Anln
anillin, actin binding protein
decreases expression
EXP
Cephaloridine results in decreased expression of ANLN mRNA
CTD
PMID:18500788
NCBI chr 8:23,336,455...23,397,122
Ensembl chr 8:23,337,621...23,390,773
G
Anxa13
annexin A13
decreases expression
EXP
Cephaloridine results in decreased expression of ANXA13 mRNA
CTD
PMID:18500788
NCBI chr 7:98,217,642...98,270,442
Ensembl chr 7:98,217,642...98,270,110
G
Anxa7
annexin A7
increases expression
EXP
Cephaloridine results in increased expression of ANXA7 mRNA
CTD
PMID:18500788
NCBI chr15:4,254,470...4,281,296
Ensembl chr15:4,254,499...4,281,287
G
Apcs
amyloid P component, serum
decreases expression
EXP
Cephaloridine results in decreased expression of APCS mRNA
CTD
PMID:18500788
NCBI chr13:91,426,621...91,427,417
Ensembl chr13:91,426,479...91,427,575
G
Apoa4
apolipoprotein A4
increases expression
EXP
Cephaloridine results in increased expression of APOA4 mRNA
CTD
PMID:18500788
NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376
G
Apob
apolipoprotein B
increases expression
EXP
Cephaloridine results in increased expression of APOB mRNA
CTD
PMID:18500788
NCBI chr 6:33,176,826...33,216,381
Ensembl chr 6:33,176,778...33,224,997
G
Apoc2
apolipoprotein C2
increases expression
EXP
Cephaloridine results in increased expression of APOC2 mRNA
CTD
PMID:18500788
NCBI chr 1:80,589,023...80,593,991
Ensembl chr 1:80,589,023...80,594,136
G
Apold1
apolipoprotein L domain containing 1
decreases expression
EXP
Cephaloridine results in decreased expression of APOLD1 mRNA
CTD
PMID:18500788
NCBI chr 4:168,752,142...168,755,024
Ensembl chr 4:168,752,133...168,755,023
G
Arfgef3
ARFGEF family member 3
decreases expression
EXP
Cephaloridine results in decreased expression of ARFGEF3 mRNA
CTD
PMID:18500788
NCBI chr 1:13,837,861...13,918,277
Ensembl chr 1:13,838,707...13,915,594
G
Arhgap35
Rho GTPase activating protein 35
decreases expression
EXP
Cephaloridine results in decreased expression of ARHGAP35 mRNA
CTD
PMID:18500788
NCBI chr 1:78,456,409...78,573,374
Ensembl chr 1:78,456,409...78,573,374
G
Arid5a
AT-rich interaction domain 5A
increases expression
EXP
Cephaloridine results in increased expression of ARID5A mRNA
CTD
PMID:18500788
NCBI chr 9:42,871,907...42,886,725
Ensembl chr 9:42,871,950...42,884,855
G
Asf1b
anti-silencing function 1B histone chaperone
increases expression
EXP
Cephaloridine results in increased expression of ASF1B mRNA
CTD
PMID:18500788
NCBI chr19:25,077,918...25,092,491
Ensembl chr19:25,077,918...25,092,491
G
Ash1l
ASH1 like histone lysine methyltransferase
decreases expression
EXP
Cephaloridine results in decreased expression of ASH1L mRNA
CTD
PMID:18500788
NCBI chr 2:188,252,592...188,389,251
Ensembl chr 2:188,253,220...188,389,250
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
Cephaloridine results in increased expression of ASNS mRNA
CTD
PMID:18500788
NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
G
Atad1
ATPase family, AAA domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of ATAD1 mRNA
CTD
PMID:18500788
NCBI chr 1:251,234,702...251,386,996
Ensembl chr 1:251,235,508...251,387,002
G
Atad2
ATPase family, AAA domain containing 2
increases expression
EXP
Cephaloridine results in increased expression of ATAD2 mRNA
CTD
PMID:18500788
NCBI chr 7:97,984,754...98,027,379
Ensembl chr 7:97,984,862...98,026,052
G
Atf3
activating transcription factor 3
decreases expression
EXP
Cephaloridine results in decreased expression of ATF3 mRNA
CTD
PMID:18500788
NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
G
Atl1
atlastin GTPase 1
increases expression
EXP
Cephaloridine results in increased expression of ATL1 mRNA
CTD
PMID:18500788
NCBI chr 6:92,229,764...92,370,428
Ensembl chr 6:92,229,686...92,370,421
G
Atp11c
ATPase phospholipid transporting 11C
decreases expression
EXP
Cephaloridine results in decreased expression of ATP11C mRNA
CTD
PMID:18500788
NCBI chr X:143,340,712...143,525,588
Ensembl chr X:143,346,252...143,453,612
G
Atp12a
ATPase H+/K+ transporting non-gastric alpha2 subunit
increases expression
EXP
Cephaloridine results in increased expression of ATP12A mRNA
CTD
PMID:18500788
NCBI chr15:36,561,306...36,590,171
Ensembl chr15:36,565,495...36,590,171
G
Aurkb
aurora kinase B
decreases expression
EXP
Cephaloridine results in decreased expression of AURKB mRNA
CTD
PMID:18500788
NCBI chr10:55,625,860...55,632,399
Ensembl chr10:55,626,741...55,634,991
G
B3galt2
Beta-1,3-galactosyltransferase 2
decreases expression
EXP
Cephaloridine results in decreased expression of B3GALT2 mRNA
CTD
PMID:18500788
NCBI chr13:60,435,946...60,444,957
Ensembl chr13:60,435,946...60,444,957
G
B3gnt7
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
decreases expression
EXP
Cephaloridine results in decreased expression of B3GNT7 mRNA
CTD
PMID:18500788
NCBI chr 9:93,326,283...93,330,234
Ensembl chr 9:93,326,283...93,330,233
G
Bag3
BAG cochaperone 3
increases expression
EXP
Cephaloridine results in increased expression of BAG3 mRNA
CTD
PMID:18500788
NCBI chr 1:199,941,258...199,965,191
Ensembl chr 1:199,941,161...199,965,191
G
Bak1
BCL2-antagonist/killer 1
increases expression
EXP
Cephaloridine results in increased expression of BAK1 mRNA
CTD
PMID:18500788
NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
G
Bard1
BRCA1 associated RING domain 1
increases expression
EXP
Cephaloridine results in increased expression of BARD1 mRNA
CTD
PMID:18500788
NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031
G
Batf
basic leucine zipper ATF-like transcription factor
increases expression
EXP
Cephaloridine results in increased expression of BATF mRNA
CTD
PMID:18500788
NCBI chr 6:109,562,415...109,584,541
Ensembl chr 6:109,562,587...109,584,545
G
Bcl2l1
Bcl2-like 1
affects expression
EXP
Cephaloridine affects the expression of BCL2L1 mRNA
CTD
PMID:18172885
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Bex1
brain expressed, X-linked 1
increases expression
EXP
Cephaloridine results in increased expression of BEX1 mRNA
CTD
PMID:18500788
NCBI chr X:106,761,388...106,771,656
G
Bex4
brain expressed, X-linked 4
increases expression
EXP
Cephaloridine results in increased expression of BEX4 mRNA
CTD
PMID:18500788
G
Bhlhe41
basic helix-loop-helix family, member e41
increases expression
EXP
Cephaloridine results in increased expression of BHLHE41 mRNA
CTD
PMID:18500788
NCBI chr 4:180,230,742...180,235,138
Ensembl chr 4:180,232,382...180,234,804
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
EXP
Cephaloridine results in increased expression of BIRC3 mRNA
CTD
PMID:18500788
NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598
G
Blvrb
biliverdin reductase B
increases expression
EXP
Cephaloridine results in increased expression of BLVRB mRNA
CTD
PMID:18500788
NCBI chr 1:84,256,063...84,273,726
Ensembl chr 1:84,256,159...84,274,075
G
Bpi
bactericidal/permeability-increasing protein
increases expression
EXP
Cephaloridine results in increased expression of BPI mRNA
CTD
PMID:18500788
NCBI chr 3:154,741,627...154,768,584
Ensembl chr 3:154,741,631...154,768,640
G
Brip1
BRCA1 interacting protein C-terminal helicase 1
increases expression
EXP
Cephaloridine results in increased expression of BRIP1 mRNA
CTD
PMID:18500788
NCBI chr10:73,507,009...73,632,742
Ensembl chr10:73,507,100...73,629,581
G
Bsnd
barttin CLCNK type accessory subunit beta
increases expression
EXP
Cephaloridine results in increased expression of BSND mRNA
CTD
PMID:18500788
NCBI chr 5:126,071,849...126,080,647
Ensembl chr 5:126,071,846...126,080,698
G
Btg2
BTG anti-proliferation factor 2
decreases expression
EXP
Cephaloridine results in decreased expression of BTG2 mRNA
CTD
PMID:18500788
NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
EXP
Cephaloridine results in decreased expression of BUB1B mRNA
CTD
PMID:18500788
NCBI chr 3:110,367,949...110,420,471
Ensembl chr 3:110,367,939...110,420,458
G
C1qtnf1
C1q and TNF related 1
increases expression
EXP
Cephaloridine results in increased expression of C1QTNF1 mRNA
CTD
PMID:18500788
NCBI chr10:107,455,845...107,477,160
Ensembl chr10:107,455,845...107,477,162
G
C5
complement C5
decreases expression
EXP
Cephaloridine results in decreased expression of C5 mRNA
CTD
PMID:18500788
NCBI chr 3:14,049,993...14,113,931 NCBI chr 3:14,206,466...14,229,141
Ensembl chr 3:14,049,995...14,229,080
G
C6
complement C6
increases expression
EXP
Cephaloridine results in increased expression of C6 mRNA
CTD
PMID:18500788
NCBI chr 2:54,460,333...54,533,801
Ensembl chr 2:54,466,280...54,533,797
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
increases expression
EXP
Cephaloridine results in increased expression of CACNA1H mRNA
CTD
PMID:18500788
NCBI chr10:14,730,932...14,789,201
Ensembl chr10:14,730,941...14,788,617
G
Cacng3
calcium voltage-gated channel auxiliary subunit gamma 3
increases expression
EXP
Cephaloridine results in increased expression of CACNG3 mRNA
CTD
PMID:18500788
NCBI chr 1:192,613,766...192,708,371
Ensembl chr 1:192,613,372...192,709,078
G
Calb1
calbindin 1
increases expression
EXP
Cephaloridine results in increased expression of CALB1 mRNA
CTD
PMID:18500788
NCBI chr 5:29,538,380...29,562,774
Ensembl chr 5:29,538,380...29,562,773
G
Calb2
calbindin 2
decreases expression
EXP
Cephaloridine results in decreased expression of CALB2 mRNA
CTD
PMID:18500788
NCBI chr19:41,482,743...41,509,617
Ensembl chr19:41,482,728...41,509,658
G
Calr
calreticulin
increases expression
EXP
Cephaloridine results in increased expression of CALR mRNA
CTD
PMID:18172885
NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
G
Camkv
CaM kinase-like vesicle-associated
increases expression
EXP
Cephaloridine results in increased expression of CAMKV mRNA
CTD
PMID:18500788
NCBI chr 8:116,715,755...116,730,061
Ensembl chr 8:116,715,755...116,730,061
G
Canx
calnexin
increases expression
EXP
Cephaloridine results in increased expression of CANX mRNA
CTD
PMID:18172885
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
G
Cat
catalase
affects expression
EXP
Cephaloridine affects the expression of CAT protein
CTD
PMID:9933756
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Ccdc113
coiled-coil domain containing 113
increases expression
EXP
Cephaloridine results in increased expression of CCDC113 mRNA
CTD
PMID:18500788
NCBI chr19:9,912,124...9,932,183
Ensembl chr19:9,912,183...9,931,930
G
Ccl17
C-C motif chemokine ligand 17
increases expression
EXP
Cephaloridine results in increased expression of CCL17 mRNA
CTD
PMID:18500788
NCBI chr19:10,619,220...10,620,671
Ensembl chr19:10,619,220...10,620,671
G
Ccl19
C-C motif chemokine ligand 19
increases expression
EXP
Cephaloridine results in increased expression of CCL19 mRNA
CTD
PMID:18500788
NCBI chr 5:58,181,025...58,182,969
Ensembl chr 5:58,181,026...58,183,017
G
Ccl20
C-C motif chemokine ligand 20
increases expression
EXP
Cephaloridine results in increased expression of CCL20 mRNA
CTD
PMID:18500788
NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001
G
Ccl28
C-C motif chemokine ligand 28
increases expression
EXP
Cephaloridine results in increased expression of CCL28 mRNA
CTD
PMID:18500788
NCBI chr 2:52,379,341...52,403,979
Ensembl chr 2:52,379,341...52,404,246
G
Ccl3
C-C motif chemokine ligand 3
decreases expression
EXP
Cephaloridine results in decreased expression of CCL3 mRNA
CTD
PMID:18500788
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
EXP
Cephaloridine results in decreased expression of CCL4 mRNA
CTD
PMID:18500788
NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
G
Ccn2
cellular communication network factor 2
decreases expression
EXP
Cephaloridine results in decreased expression of CCN2 mRNA
CTD
PMID:18500788
NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
G
Ccna2
cyclin A2
decreases expression
EXP
Cephaloridine results in decreased expression of CCNA2 mRNA
CTD
PMID:18500788
NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
G
Ccnb1
cyclin B1
decreases expression
EXP
Cephaloridine results in decreased expression of CCNB1 mRNA
CTD
PMID:18500788
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
G
Ccnb2
cyclin B2
decreases expression
EXP
Cephaloridine results in decreased expression of CCNB2 mRNA
CTD
PMID:18500788
NCBI chr 8:76,847,972...76,861,165
G
Ccne1
cyclin E1
increases expression
EXP
Cephaloridine results in increased expression of CCNE1 mRNA
CTD
PMID:18500788
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
G
Ccne2
cyclin E2
increases expression
EXP
Cephaloridine results in increased expression of CCNE2 mRNA
CTD
PMID:18500788
NCBI chr 5:24,434,077...24,446,406
Ensembl chr 5:24,434,872...24,446,406
G
Cd52
CD52 molecule
decreases expression
EXP
Cephaloridine results in decreased expression of CD52 mRNA
CTD
PMID:18500788
NCBI chr 5:152,322,910...152,324,469
Ensembl chr 5:152,322,916...152,324,469
G
Cd72
Cd72 molecule
increases expression
EXP
Cephaloridine results in increased expression of CD72 mRNA
CTD
PMID:18500788
NCBI chr 5:58,943,021...58,950,373
Ensembl chr 5:58,943,027...58,950,373
G
Cd86
CD86 molecule
increases expression
EXP
Cephaloridine results in increased expression of CD86 mRNA
CTD
PMID:18500788
NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
G
Cdc42
cell division cycle 42
decreases expression
EXP
Cephaloridine results in decreased expression of CDC42 mRNA
CTD
PMID:18172885
NCBI chr 5:155,690,267...155,728,385
Ensembl chr 5:155,691,390...155,728,300
G
Cdc45
cell division cycle 45
increases expression
EXP
Cephaloridine results in increased expression of CDC45 mRNA
CTD
PMID:18500788
NCBI chr11:86,328,785...86,354,099
Ensembl chr11:86,329,012...86,358,453
G
Cdc6
cell division cycle 6
increases expression
EXP
Cephaloridine results in increased expression of CDC6 mRNA
CTD
PMID:18500788
NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402
G
Cdca2
cell division cycle associated 2
decreases expression
EXP
Cephaloridine results in decreased expression of CDCA2 mRNA
CTD
PMID:18500788
NCBI chr15:44,365,396...44,411,601
Ensembl chr15:44,365,405...44,411,004
G
Cdk1
cyclin-dependent kinase 1
decreases expression
EXP
Cephaloridine results in decreased expression of CDK1 mRNA
CTD
PMID:18500788
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
G
Cdkl1
cyclin dependent kinase like 1
decreases expression
EXP
Cephaloridine results in decreased expression of CDKL1 mRNA
CTD
PMID:18500788
NCBI chr 6:92,076,247...92,123,108
Ensembl chr 6:92,077,416...92,121,351
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
EXP
Cephaloridine results in decreased expression of CDKN1A mRNA
CTD
PMID:18500788
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
EXP
Cephaloridine results in decreased expression of CDKN1B mRNA
CTD
PMID:18500788
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
G
Cdt1
chromatin licensing and DNA replication factor 1
increases expression
EXP
Cephaloridine results in increased expression of CDT1 mRNA
CTD
PMID:18500788
NCBI chr19:55,381,565...55,386,511
Ensembl chr19:55,381,565...55,386,511
G
Ceacam16
CEA cell adhesion molecule 16, tectorial membrane component
increases expression
EXP
Cephaloridine results in increased expression of CEACAM16 mRNA
CTD
PMID:18500788
NCBI chr 1:80,773,819...80,783,898
Ensembl chr 1:80,773,819...80,783,898
G
Cenpk
centromere protein K
increases expression
EXP
Cephaloridine results in increased expression of CENPK mRNA
CTD
PMID:18500788
NCBI chr 2:34,312,766...34,373,945
Ensembl chr 2:34,312,766...34,335,776
G
Cenpq
centromere protein Q
increases expression
EXP
Cephaloridine results in increased expression of CENPQ mRNA
CTD
PMID:18500788
NCBI chr 9:23,352,271...23,368,774
G
Cesl1
carboxylesterase-like 1
decreases expression
EXP
Cephaloridine results in decreased expression of CESL1 mRNA
CTD
PMID:18500788
Ensembl chr19:15,081,158...15,335,002
G
Chaf1a
chromatin assembly factor 1 subunit A
increases expression
EXP
Cephaloridine results in increased expression of CHAF1A mRNA
CTD
PMID:18500788
NCBI chr 9:11,000,869...11,027,631
Ensembl chr 9:11,001,129...11,027,506
G
Chaf1b
chromatin assembly factor 1 subunit B
increases expression
EXP
Cephaloridine results in increased expression of CHAF1B mRNA
CTD
PMID:18500788
NCBI chr11:34,101,248...34,121,371
Ensembl chr11:34,101,197...34,121,378
G
Chd4
chromodomain helicase DNA binding protein 4
decreases expression
EXP
Cephaloridine results in decreased expression of CHD4 mRNA
CTD
PMID:18500788
NCBI chr 4:157,612,531...157,645,660
Ensembl chr 4:157,612,536...157,645,659
G
Chd6
chromodomain helicase DNA binding protein 6
decreases expression
EXP
Cephaloridine results in decreased expression of CHD6 mRNA
CTD
PMID:18500788
NCBI chr 3:156,937,746...157,099,328
Ensembl chr 3:156,937,733...157,099,306
G
Chek1
checkpoint kinase 1
increases expression
EXP
Cephaloridine results in increased expression of CHEK1 mRNA
CTD
PMID:18500788
NCBI chr 8:39,181,162...39,201,588
Ensembl chr 8:39,181,163...39,243,882
G
Chst7
carbohydrate sulfotransferase 7
decreases expression
EXP
Cephaloridine results in decreased expression of CHST7 mRNA
CTD
PMID:18500788
NCBI chr X:2,623,018...2,657,155
Ensembl chr X:2,623,024...2,657,155
G
Chtf18
chromosome transmission fidelity factor 18
increases expression
EXP
Cephaloridine results in increased expression of CHTF18 mRNA
CTD
PMID:18500788
NCBI chr10:15,090,762...15,098,825
Ensembl chr10:15,090,316...15,098,791
G
Cilp
cartilage intermediate layer protein
decreases expression
EXP
Cephaloridine results in decreased expression of CILP mRNA
CTD
PMID:18500788
NCBI chr 8:70,760,922...70,775,891
Ensembl chr 8:70,760,922...70,775,891
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
EXP
Cephaloridine results in increased expression of CITED2 mRNA
CTD
PMID:18172885
NCBI chr 1:12,823,363...12,825,806
Ensembl chr 1:12,823,363...12,825,786
G
Ckap2
cytoskeleton associated protein 2
decreases expression
EXP
Cephaloridine results in decreased expression of CKAP2 mRNA
CTD
PMID:18500788
NCBI chr16:74,752,655...74,779,184
Ensembl chr16:74,752,655...74,779,184
G
Cldn14
claudin 14
increases expression
EXP
Cephaloridine results in increased expression of CLDN14 mRNA
CTD
PMID:18500788
NCBI chr11:34,132,581...34,142,813
Ensembl chr11:34,132,581...34,142,753
G
Clstn2
calsyntenin 2
decreases expression
EXP
Cephaloridine results in decreased expression of CLSTN2 mRNA
CTD
PMID:18500788
NCBI chr 8:105,322,577...106,036,821
Ensembl chr 8:105,323,837...105,462,168
G
Cmip
c-Maf-inducing protein
decreases expression
EXP
Cephaloridine results in decreased expression of CMIP mRNA
CTD
PMID:18500788
NCBI chr19:49,792,273...50,000,535
Ensembl chr19:49,792,273...50,000,535
G
Cndp1
carnosine dipeptidase 1
decreases expression
EXP
Cephaloridine results in decreased expression of CNDP1 mRNA
CTD
PMID:18500788
NCBI chr18:81,466,717...81,512,841
Ensembl chr18:81,466,716...81,499,051
G
Col4a4
collagen type IV alpha 4 chain
decreases expression
EXP
Cephaloridine results in decreased expression of COL4A4 mRNA
CTD
PMID:18500788
NCBI chr 9:88,314,763...88,357,183
Ensembl chr 9:88,232,455...88,357,182
G
Col7a1
collagen type VII alpha 1 chain
increases expression
EXP
Cephaloridine results in increased expression of COL7A1 mRNA
CTD
PMID:18500788
NCBI chr 8:117,694,441...117,726,844
Ensembl chr 8:117,694,605...117,726,844
G
Cpt1b
carnitine palmitoyltransferase 1B
increases expression
EXP
Cephaloridine results in increased expression of CPT1B mRNA
CTD
PMID:18500788
NCBI chr 7:130,395,211...130,404,731
Ensembl chr 7:130,395,194...130,405,347
G
Crabp1
cellular retinoic acid binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of CRABP1 mRNA
CTD
PMID:18500788
NCBI chr 8:59,344,097...59,352,135
Ensembl chr 8:59,344,083...59,352,132
G
Crebbp
CREB binding protein
decreases expression
EXP
Cephaloridine results in decreased expression of CREBBP mRNA
CTD
PMID:18500788
NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
G
Cry1
cryptochrome circadian regulator 1
increases expression
EXP
Cephaloridine results in increased expression of CRY1 mRNA
CTD
PMID:18500788
NCBI chr 7:24,534,593...24,634,098
Ensembl chr 7:24,534,615...24,634,097
G
Cxcl1
C-X-C motif chemokine ligand 1
decreases expression
EXP
Cephaloridine results in decreased expression of CXCL1 mRNA
CTD
PMID:18500788
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
EXP
Cephaloridine results in increased expression of CXCL10 mRNA
CTD
PMID:18500788
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
G
Cxcl13
C-X-C motif chemokine ligand 13
increases expression
EXP
Cephaloridine results in increased expression of CXCL13 mRNA
CTD
PMID:18500788
NCBI chr14:15,253,146...15,258,221
Ensembl chr14:15,253,125...15,258,207
G
Cxcl14
C-X-C motif chemokine ligand 14
increases expression
EXP
Cephaloridine results in increased expression of CXCL14 mRNA
CTD
PMID:18500788
NCBI chr17:9,109,731...9,117,754
Ensembl chr17:9,109,731...9,117,750
G
Cxxc4
CXXC finger protein 4
decreases expression
EXP
Cephaloridine results in decreased expression of CXXC4 mRNA
CTD
PMID:18500788
NCBI chr 2:239,414,882...239,439,640
Ensembl chr 2:239,415,046...239,439,568
G
Cyb5a
cytochrome b5 type A
increases expression
EXP
Cephaloridine results in increased expression of CYB5A mRNA
CTD
PMID:18172885
NCBI chr18:81,694,818...81,726,821
Ensembl chr18:81,694,808...81,726,821
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
EXP
Cephaloridine results in increased expression of CYP1B1 mRNA
CTD
PMID:18500788
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
decreases expression
EXP
Cephaloridine results in decreased expression of CYP24A1 mRNA
CTD
PMID:18500788
NCBI chr 3:168,097,484...168,111,920
Ensembl chr 3:168,097,485...168,111,920
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases expression
EXP
Cephaloridine results in decreased expression of CYP2C mRNA
CTD
PMID:18500788
NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
increases expression
EXP
Cephaloridine results in increased expression of CYP7B1 mRNA
CTD
PMID:18500788
NCBI chr 2:102,701,903...102,871,257
Ensembl chr 2:102,701,903...102,871,257
G
Dctpp1
dCTP pyrophosphatase 1
increases expression
EXP
Cephaloridine results in increased expression of DCTPP1 mRNA
CTD
PMID:18500788
NCBI chr 1:198,703,459...198,706,852
Ensembl chr 1:198,703,461...198,706,852
G
Ddc
dopa decarboxylase
decreases expression
EXP
Cephaloridine results in decreased expression of DDC mRNA
CTD
PMID:18500788
NCBI chr14:91,905,919...91,996,816
Ensembl chr14:91,905,919...91,996,774
G
Ddit4
DNA-damage-inducible transcript 4
decreases expression
EXP
Cephaloridine results in decreased expression of DDIT4 mRNA
CTD
PMID:18500788
NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382
G
Ddit4l
DNA-damage-inducible transcript 4-like
increases expression
EXP
Cephaloridine results in increased expression of DDIT4L mRNA
CTD
PMID:18500788
NCBI chr 2:242,882,219...242,885,088
Ensembl chr 2:242,882,306...242,885,131
G
Ddx39a
DExD-box helicase 39A
increases expression
EXP
Cephaloridine results in increased expression of DDX39A mRNA
CTD
PMID:18500788
NCBI chr19:24,846,530...24,854,886
Ensembl chr19:24,846,938...24,854,953
G
Ddx6
DEAD-box helicase 6
decreases expression
EXP
Cephaloridine results in decreased expression of DDX6 mRNA
CTD
PMID:18500788
NCBI chr 8:48,924,768...48,961,394
Ensembl chr 8:48,925,604...48,958,026
G
Decr2
2,4-dienoyl-CoA reductase 2
decreases expression
EXP
Cephaloridine results in decreased expression of DECR2 mRNA
CTD
PMID:18500788
NCBI chr10:15,451,850...15,460,227
Ensembl chr10:15,431,638...15,465,413
G
Dlgap1
DLG associated protein 1
increases expression
EXP
Cephaloridine results in increased expression of DLGAP1 mRNA
CTD
PMID:18500788
NCBI chr 9:118,277,046...119,159,807
Ensembl chr 9:118,586,179...119,158,196
G
Dnah7
dynein, axonemal, heavy chain 7
decreases expression
EXP
Cephaloridine results in decreased expression of DNAH7 mRNA
CTD
PMID:18500788
NCBI chr 9:60,070,087...60,330,121 NCBI chr 9:59,564,253...59,595,347
Ensembl chr 9:60,070,739...60,330,125 Ensembl chr 9:60,070,739...60,330,125
G
Dnah9
dynein, axonemal, heavy chain 9
decreases expression
EXP
Cephaloridine results in decreased expression of DNAH9 mRNA
CTD
PMID:18500788
NCBI chr10:52,351,226...52,711,289
Ensembl chr10:52,351,192...52,710,862
G
Dnase1l3
deoxyribonuclease 1-like 3
increases expression
EXP
Cephaloridine results in increased expression of DNASE1L3 mRNA
CTD
PMID:18500788
NCBI chr15:18,710,492...18,736,476
Ensembl chr15:18,710,492...18,736,473
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
increases expression
EXP
Cephaloridine results in increased expression of DNPH1 mRNA
CTD
PMID:18500788
NCBI chr 9:16,845,764...16,848,514
Ensembl chr 9:16,845,525...16,848,503
G
Donson
DNA replication fork stabilization factor DONSON
increases expression
EXP
Cephaloridine results in increased expression of DONSON mRNA
CTD
PMID:18500788
NCBI chr11:31,834,608...31,847,751
Ensembl chr11:31,837,839...31,847,490
G
Dpf1
double PHD fingers 1
increases expression
EXP
Cephaloridine results in increased expression of DPF1 mRNA
CTD
PMID:18500788
NCBI chr 1:87,248,448...87,258,070
Ensembl chr 1:87,248,489...87,258,070
G
Dscc1
DNA replication and sister chromatid cohesion 1
increases expression
EXP
Cephaloridine results in increased expression of DSCC1 mRNA
CTD
PMID:18500788
NCBI chr 7:94,759,076...94,774,787
Ensembl chr 7:94,758,800...94,774,569
G
Dsg2
desmoglein 2
increases expression
EXP
Cephaloridine results in increased expression of DSG2 mRNA
CTD
PMID:18500788
NCBI chr18:15,579,322...15,637,720
Ensembl chr18:15,579,315...15,637,715
G
Dtx4
deltex E3 ubiquitin ligase 4
increases expression
EXP
Cephaloridine results in increased expression of DTX4 mRNA
CTD
PMID:18500788
NCBI chr 1:228,729,842...228,759,783
Ensembl chr 1:228,732,985...228,755,866
G
Dusp6
dual specificity phosphatase 6
affects expression
EXP
Cephaloridine affects the expression of DUSP6 mRNA
CTD
PMID:18172885
NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
G
Dusp7
dual specificity phosphatase 7
decreases expression
EXP
Cephaloridine results in decreased expression of DUSP7 mRNA
CTD
PMID:18500788
NCBI chr 8:115,069,095...115,076,130
Ensembl chr 8:115,069,095...115,076,130
G
Dusp9
dual specificity phosphatase 9
increases expression
EXP
Cephaloridine results in increased expression of DUSP9 mRNA
CTD
PMID:18500788
NCBI chr X:157,168,143...157,172,068
Ensembl chr X:157,168,144...157,172,068
G
E2f8
E2F transcription factor 8
increases expression
EXP
Cephaloridine results in increased expression of E2F8 mRNA
CTD
PMID:18500788
NCBI chr 1:104,185,436...104,203,683
Ensembl chr 1:104,187,100...104,202,591
G
Edrf1
erythroid differentiation regulatory factor 1
decreases expression
EXP
Cephaloridine results in decreased expression of EDRF1 mRNA
CTD
PMID:18500788
NCBI chr 1:205,706,023...205,743,676
Ensembl chr 1:205,706,468...205,743,653
G
Eef2
eukaryotic translation elongation factor 2
increases expression
EXP
Cephaloridine results in increased expression of EEF2 mRNA
CTD
PMID:18172885
NCBI chr 7:11,401,501...11,406,771
Ensembl chr 7:11,401,501...11,406,771
G
Egr1
early growth response 1
decreases expression
EXP
Cephaloridine results in decreased expression of EGR1 mRNA
CTD
PMID:18500788
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
G
Egr2
early growth response 2
decreases expression
EXP
Cephaloridine results in decreased expression of EGR2 mRNA
CTD
PMID:18500788
NCBI chr20:22,452,170...22,461,018
Ensembl chr20:22,454,463...22,459,025
G
Eif4h
eukaryotic translation initiation factor 4H
increases expression
EXP
Cephaloridine results in increased expression of EIF4H mRNA
CTD
PMID:18172885
NCBI chr12:25,093,119...25,109,805
Ensembl chr12:25,093,149...25,109,799
G
Elf3
E74 like ETS transcription factor 3
increases expression
EXP
Cephaloridine results in increased expression of ELF3 mRNA
CTD
PMID:18500788
NCBI chr13:52,083,873...52,088,798
Ensembl chr13:52,083,859...52,088,780
G
Emb
embigin
increases expression
EXP
Cephaloridine results in increased expression of EMB mRNA
CTD
PMID:18500788
NCBI chr 2:49,682,763...49,733,475
Ensembl chr 2:49,682,754...49,732,253
G
Eme1
essential meiotic structure-specific endonuclease 1
decreases expression
EXP
Cephaloridine results in decreased expression of EME1 mRNA
CTD
PMID:18500788
NCBI chr10:82,366,820...82,375,510
Ensembl chr10:82,367,084...82,374,171
G
Enc1
ectodermal-neural cortex 1
increases expression
EXP
Cephaloridine results in increased expression of ENC1 mRNA
CTD
PMID:18500788
NCBI chr 2:28,049,217...28,061,023
Ensembl chr 2:28,049,217...28,061,029
G
Eno2
enolase 2
increases expression
EXP
Cephaloridine results in increased expression of ENO2 mRNA
CTD
PMID:18500788
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
G
Espl1
extra spindle pole bodies like 1, separase
decreases expression
EXP
Cephaloridine results in decreased expression of ESPL1 mRNA
CTD
PMID:18500788
NCBI chr 7:143,896,890...143,923,868
Ensembl chr 7:143,897,014...143,923,868
G
Exo1
exonuclease 1
increases expression
EXP
Cephaloridine results in increased expression of EXO1 mRNA
CTD
PMID:18500788
NCBI chr13:93,936,989...93,962,749
Ensembl chr13:93,939,022...93,960,342
G
F13b
coagulation factor XIII B chain
decreases expression
EXP
Cephaloridine results in decreased expression of F13B mRNA
CTD
PMID:18500788
NCBI chr13:56,598,891...56,623,132
Ensembl chr13:56,598,957...56,623,124
G
Fam111a
FAM111 trypsin like peptidase A
decreases expression
EXP
Cephaloridine results in decreased expression of FAM111A mRNA
CTD
PMID:18500788
NCBI chr 1:229,003,778...229,019,532
Ensembl chr 1:229,003,961...229,019,527
G
Fam189a2
family with sequence similarity 189, member A2
increases expression
EXP
Cephaloridine results in increased expression of FAM189A2 mRNA
CTD
PMID:18500788
NCBI chr 1:241,822,152...241,876,089
Ensembl chr 1:241,822,626...241,875,864
G
Fam71a
family with sequence similarity 71, member A
increases expression
EXP
Cephaloridine results in increased expression of FAM71A mRNA
CTD
PMID:18500788
NCBI chr13:109,768,019...109,770,199
Ensembl chr13:109,768,019...109,770,199
G
Fancd2
FA complementation group D2
increases expression
EXP
Cephaloridine results in increased expression of FANCD2 mRNA
CTD
PMID:18500788
NCBI chr 4:145,489,869...145,551,479
Ensembl chr 4:145,489,869...145,551,479
G
Fbln1
fibulin 1
increases expression
EXP
Cephaloridine results in increased expression of FBLN1 mRNA
CTD
PMID:18500788
NCBI chr 7:126,096,793...126,176,468
Ensembl chr 7:126,096,793...126,176,468
G
Fbp2
fructose-bisphosphatase 2
increases expression
EXP
Cephaloridine results in increased expression of FBP2 mRNA
CTD
PMID:18500788
NCBI chr17:372,554...389,918
Ensembl chr17:372,551...389,967
G
Fbxo5
F-box protein 5
increases expression
EXP
Cephaloridine results in increased expression of FBXO5 mRNA
CTD
PMID:18500788
NCBI chr 1:42,461,277...42,467,646
Ensembl chr 1:42,461,291...42,467,586
G
Fcgr2a
Fc fragment of IgG receptor IIa
increases expression
EXP
Cephaloridine results in increased expression of FCGR2A mRNA
CTD
PMID:18500788
NCBI chr13:91,146,878...91,163,691
Ensembl chr13:91,168,973...91,198,036 Ensembl chr13:91,168,973...91,198,036
G
Fcgr2b
Fc fragment of IgG receptor IIb
increases expression
EXP
Cephaloridine results in increased expression of FCGR2B mRNA
CTD
PMID:18500788
NCBI chr13:89,329,298...89,343,916
Ensembl chr13:89,327,794...89,433,815
G
Fcgr3a
Fc fragment of IgG receptor IIIa
increases expression
EXP
Cephaloridine results in increased expression of FCGR3A mRNA
CTD
PMID:18500788
NCBI chr13:89,385,775...89,396,047
Ensembl chr13:89,385,859...89,396,051
G
Fcnb
ficolin B
increases expression
EXP
Cephaloridine results in increased expression of FCNB mRNA
CTD
PMID:18500788
NCBI chr 3:6,617,816...6,626,193
Ensembl chr 3:6,617,751...6,626,284
G
Fen1
flap structure-specific endonuclease 1
increases expression
EXP
Cephaloridine results in increased expression of FEN1 mRNA
CTD
PMID:18500788
NCBI chr 1:226,251,516...226,256,160
Ensembl chr 1:226,251,518...226,255,886
G
Fgb
fibrinogen beta chain
increases expression
EXP
Cephaloridine results in increased expression of FGB mRNA
CTD
PMID:18500788
NCBI chr 2:182,028,044...182,035,026
Ensembl chr 2:182,027,115...182,038,178
G
Fgf17
fibroblast growth factor 17
increases expression
EXP
Cephaloridine results in increased expression of FGF17 mRNA
CTD
PMID:18500788
NCBI chr15:52,326,758...52,337,360
Ensembl chr15:52,326,778...52,332,097
G
Fgl2
fibrinogen-like 2
increases expression
EXP
Cephaloridine results in increased expression of FGL2 mRNA
CTD
PMID:18500788
NCBI chr 4:10,323,598...10,329,241
Ensembl chr 4:10,323,607...10,329,241
G
Fhdc1
FH2 domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of FHDC1 mRNA
CTD
PMID:18500788
NCBI chr 2:183,450,608...183,487,820
Ensembl chr 2:183,450,619...183,487,820
G
Filip1
filamin A interacting protein 1
decreases expression
EXP
Cephaloridine results in decreased expression of FILIP1 mRNA
CTD
PMID:18500788
NCBI chr 8:87,257,312...87,453,432
Ensembl chr 8:87,256,264...87,419,564
G
Folh1
folate hydrolase 1
decreases expression
EXP
Cephaloridine results in decreased expression of FOLH1 mRNA
CTD
PMID:18500788
NCBI chr 1:150,323,768...150,395,415
Ensembl chr 1:150,323,768...150,395,415
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Cephaloridine results in decreased expression of FOS mRNA
CTD
PMID:18500788
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Foxe1
forkhead box E1
decreases expression
EXP
Cephaloridine results in decreased expression of FOXE1 mRNA
CTD
PMID:18500788
NCBI chr 5:61,954,549...61,957,357
Ensembl chr 5:61,954,549...61,957,357
G
Foxq1
forkhead box Q1
increases expression
EXP
Cephaloridine results in increased expression of FOXQ1 mRNA
CTD
PMID:18500788
NCBI chr17:34,224,308...34,226,941
Ensembl chr17:34,224,818...34,226,453
G
Fyco1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
EXP
Cephaloridine results in decreased expression of FYCO1 mRNA
CTD
PMID:18500788
NCBI chr 8:132,844,042...132,910,905
Ensembl chr 8:132,844,043...132,911,193
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
Cephaloridine results in decreased expression of G6PC1 mRNA
CTD
PMID:18500788
NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
EXP
Cephaloridine results in increased expression of G6PD mRNA
CTD
PMID:18500788
NCBI chr X:156,274,800...156,293,935
Ensembl chr X:156,274,800...156,293,926
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
EXP
Cephaloridine results in increased expression of GADD45A mRNA
CTD
PMID:18172885
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
G
Galnt13
polypeptide N-acetylgalactosaminyltransferase 13
increases expression
EXP
Cephaloridine results in increased expression of GALNT13 mRNA
CTD
PMID:18500788
NCBI chr 3:39,967,056...40,625,144
Ensembl chr 3:40,038,336...40,624,530
G
Ganc
glucosidase, alpha; neutral C
decreases expression
EXP
Cephaloridine results in decreased expression of GANC mRNA
CTD
PMID:18500788
NCBI chr 3:112,173,907...112,226,886
Ensembl chr 3:112,173,907...112,226,023
G
Gba3
glucosylceramidase beta 3
decreases expression
EXP
Cephaloridine results in decreased expression of GBA3 mRNA
CTD
PMID:18500788
NCBI chr14:64,390,793...64,535,213
Ensembl chr14:64,390,793...64,535,170
G
Gda
guanine deaminase
increases expression
EXP
Cephaloridine results in increased expression of GDA mRNA
CTD
PMID:18500788
NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732
G
Gdf15
growth differentiation factor 15
decreases expression
EXP
Cephaloridine results in decreased expression of GDF15 mRNA
CTD
PMID:18500788
NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978
G
Gfra2
GDNF family receptor alpha 2
decreases expression
EXP
Cephaloridine results in decreased expression of GFRA2 mRNA
CTD
PMID:18500788
NCBI chr15:52,557,004...52,648,984
Ensembl chr15:52,557,607...52,648,972
G
Gins2
GINS complex subunit 2
increases expression
EXP
Cephaloridine results in increased expression of GINS2 mRNA
CTD
PMID:18500788
NCBI chr19:54,151,048...54,163,701
Ensembl chr19:54,151,048...54,163,608
G
Gins4
GINS complex subunit 4
increases expression
EXP
Cephaloridine results in increased expression of GINS4 mRNA
CTD
PMID:18500788
NCBI chr16:73,584,412...73,596,808
Ensembl chr16:73,584,521...73,596,793
G
Gmnn
geminin, DNA replication inhibitor
increases expression
EXP
Cephaloridine results in increased expression of GMNN mRNA
CTD
PMID:18500788
NCBI chr17:42,302,523...42,310,783
Ensembl chr17:42,302,540...42,310,783
G
Gna14
G protein subunit alpha 14
increases expression
EXP
Cephaloridine results in increased expression of GNA14 mRNA
CTD
PMID:18500788
NCBI chr 1:235,165,775...235,347,986
Ensembl chr 1:235,166,718...235,347,937
G
Gpnmb
glycoprotein nmb
increases expression
EXP
Cephaloridine results in increased expression of GPNMB mRNA
CTD
PMID:18500788
NCBI chr 4:78,694,447...78,715,685
Ensembl chr 4:78,694,447...78,715,683
G
Gpr135
G protein-coupled receptor 135
decreases expression
EXP
Cephaloridine results in decreased expression of GPR135 mRNA
CTD
PMID:18500788
NCBI chr 6:94,816,976...94,818,349
Ensembl chr 6:94,816,976...94,818,349
G
Gpr19
G protein-coupled receptor 19
increases expression
EXP
Cephaloridine results in increased expression of GPR19 mRNA
CTD
PMID:18500788
NCBI chr 4:168,639,930...168,668,345
Ensembl chr 4:168,639,940...168,656,673
G
Gpx2
glutathione peroxidase 2
increases expression
EXP
Cephaloridine results in increased expression of GPX2 mRNA
CTD
PMID:18500788
NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
decreases expression
EXP
Cephaloridine results in decreased expression of GRIA3 mRNA
CTD
PMID:18500788
NCBI chr X:127,561,843...127,829,763
Ensembl chr X:127,562,660...127,829,753
G
Gsr
glutathione-disulfide reductase
increases expression
EXP
Cephaloridine results in increased expression of GSR mRNA
CTD
PMID:18172885
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
G
Gsta2
glutathione S-transferase alpha 2
increases expression
EXP
Cephaloridine results in increased expression of GSTA2 mRNA
CTD
PMID:18172885
NCBI chr 8:85,640,081...85,645,621
G
Gsta5
glutathione S-transferase alpha 5
increases expression
EXP
Cephaloridine results in increased expression of GSTA5 mRNA
CTD
PMID:18172885
NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179
G
Gstm1
glutathione S-transferase mu 1
increases expression
EXP
Cephaloridine results in increased expression of GSTM1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP
Cephaloridine results in increased expression of GSTP1 mRNA
CTD
PMID:18500788
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
G
Gxylt1
glucoside xylosyltransferase 1
decreases expression
EXP
Cephaloridine results in decreased expression of GXYLT1 mRNA
CTD
PMID:18500788
NCBI chr 7:134,447,578...134,495,858
Ensembl chr 7:134,447,578...134,495,835
G
H1f1
H1.1 linker histone, cluster member
increases expression
EXP
Cephaloridine results in increased expression of H1F1 mRNA
CTD
PMID:18500788
NCBI chr17:43,614,101...43,614,844
Ensembl chr17:43,614,101...43,614,844
G
Hadh
hydroxyacyl-CoA dehydrogenase
decreases expression
EXP
Cephaloridine results in decreased expression of HADH mRNA
CTD
PMID:18500788
NCBI chr 2:236,353,445...236,395,067
Ensembl chr 2:236,353,445...236,395,067
G
Haus8
HAUS augmin-like complex, subunit 8
increases expression
EXP
Cephaloridine results in increased expression of HAUS8 mRNA
CTD
PMID:18500788
NCBI chr16:19,654,785...19,669,221
Ensembl chr16:19,654,798...19,669,196
G
Havcr1
hepatitis A virus cellular receptor 1
increases expression
EXP
Cephaloridine results in increased expression of HAVCR1 mRNA
CTD
PMID:18500788 PMID:20305092
NCBI chr10:31,813,819...31,860,934
Ensembl chr10:31,813,814...31,848,379
G
Hck
HCK proto-oncogene, Src family tyrosine kinase
increases expression
EXP
Cephaloridine results in increased expression of HCK mRNA
CTD
PMID:18500788
NCBI chr 3:148,579,917...148,623,026
Ensembl chr 3:148,579,920...148,623,033
G
Hebp1
heme binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of HEBP1 mRNA
CTD
PMID:18500788
NCBI chr 4:168,903,586...168,933,102
Ensembl chr 4:168,903,565...168,933,079
G
Hebp2
heme binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of HEBP2 mRNA
CTD
PMID:18500788
NCBI chr 1:13,713,152...13,719,970
Ensembl chr 1:13,714,440...13,719,829
G
Hells
helicase, lymphoid specific
increases expression
EXP
Cephaloridine results in increased expression of HELLS mRNA
CTD
PMID:18500788
NCBI chr 1:257,901,856...257,953,889
Ensembl chr 1:257,766,691...257,949,183 Ensembl chr 1:257,766,691...257,949,183
G
Hepacam2
HEPACAM family member 2
increases expression
EXP
Cephaloridine results in increased expression of HEPACAM2 mRNA
CTD
PMID:18500788
NCBI chr 4:28,402,862...28,437,722
Ensembl chr 4:28,403,125...28,437,676
G
Hjv
hemojuvelin BMP co-receptor
decreases expression
EXP
Cephaloridine results in decreased expression of HJV mRNA
CTD
PMID:18500788
NCBI chr 2:198,655,437...198,659,318
Ensembl chr 2:198,655,437...198,659,317
G
Hlx
H2.0-like homeobox
decreases expression
EXP
Cephaloridine results in decreased expression of HLX mRNA
CTD
PMID:18500788
NCBI chr13:102,637,967...102,643,376
Ensembl chr13:102,637,769...102,643,223
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
EXP
Cephaloridine results in decreased expression of HMGCS2 mRNA
CTD
PMID:18500788
NCBI chr 2:200,452,623...200,480,785
Ensembl chr 2:200,452,624...200,479,423
G
Hmox1
heme oxygenase 1
increases expression
EXP
Cephaloridine results in increased expression of HMOX1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Hmx3
H6 family homeobox 3
increases expression
EXP
Cephaloridine results in increased expression of HMX3 mRNA
CTD
PMID:18500788
NCBI chr 1:203,509,731...203,511,695
Ensembl chr 1:203,509,731...203,511,695
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
increases expression
EXP
Cephaloridine results in increased expression of HNRNPA1 mRNA
CTD
PMID:18500788
NCBI chr 7:144,865,302...144,871,592
Ensembl chr 7:144,865,608...144,871,585
G
Hrg
histidine-rich glycoprotein
decreases expression
EXP
Cephaloridine results in decreased expression of HRG mRNA
CTD
PMID:18500788
NCBI chr11:81,621,274...81,639,938
Ensembl chr11:81,621,283...81,639,952
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
EXP
Cephaloridine results in decreased expression of HSD17B2 mRNA
CTD
PMID:18500788
NCBI chr19:50,246,404...50,317,892
Ensembl chr19:50,246,402...50,317,891
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
increases expression
EXP
Cephaloridine results in increased expression of HSD3B1 mRNA
CTD
PMID:18500788
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
EXP
Cephaloridine results in increased expression of HSP90AA1 mRNA
CTD
PMID:18500788
NCBI chr 6:135,107,262...135,112,793
Ensembl chr 6:135,107,271...135,112,775
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
EXP
Cephaloridine results in increased expression of HSPA1A mRNA
CTD
PMID:18500788
NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
EXP
Cephaloridine results in increased expression of HSPA1B mRNA
CTD
PMID:18500788
NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
EXP
Cephaloridine results in increased expression of HSPH1 mRNA
CTD
PMID:18500788
NCBI chr12:6,322,685...6,341,898
Ensembl chr12:6,322,668...6,341,902
G
Htatip2
HIV-1 Tat interactive protein 2
increases expression
EXP
Cephaloridine results in increased expression of HTATIP2 mRNA
CTD
PMID:18500788
NCBI chr 1:105,094,272...105,109,459
Ensembl chr 1:105,094,411...105,109,461
G
Icam1
intercellular adhesion molecule 1
increases expression
EXP
Cephaloridine results in increased expression of ICAM1 mRNA
CTD
PMID:18500788
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
G
Ier3
immediate early response 3
decreases expression
EXP
Cephaloridine results in decreased expression of IER3 mRNA
CTD
PMID:18500788
NCBI chr20:3,438,798...3,440,002
Ensembl chr20:3,438,798...3,440,769
G
Ifitm10
interferon induced transmembrane protein 10
increases expression
EXP
Cephaloridine results in increased expression of IFITM10 mRNA
CTD
PMID:18500788
NCBI chr 1:215,521,604...215,538,283
Ensembl chr 1:215,515,764...215,536,980
G
Il18
interleukin 18
increases expression
EXP
Cephaloridine results in increased expression of IL18 mRNA
CTD
PMID:18500788
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
G
Il1b
interleukin 1 beta
decreases expression
EXP
Cephaloridine results in decreased expression of IL1B mRNA
CTD
PMID:18500788
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il20ra
interleukin 20 receptor subunit alpha
decreases expression
EXP
Cephaloridine results in decreased expression of IL20RA mRNA
CTD
PMID:18500788
NCBI chr 1:15,180,328...15,222,785
Ensembl chr 1:15,180,328...15,222,785
G
Inhbb
inhibin subunit beta B
decreases expression
EXP
Cephaloridine results in decreased expression of INHBB mRNA
CTD
PMID:18500788
NCBI chr13:35,436,532...35,442,222
Ensembl chr13:35,436,532...35,442,222
G
Itpka
inositol-trisphosphate 3-kinase A
increases expression
EXP
Cephaloridine results in increased expression of ITPKA mRNA
CTD
PMID:18500788
NCBI chr 3:111,545,007...111,553,605
Ensembl chr 3:111,545,007...111,553,604
G
Itpkb
inositol-trisphosphate 3-kinase B
increases expression
EXP
Cephaloridine results in increased expression of ITPKB mRNA
CTD
PMID:18500788
NCBI chr13:98,615,287...98,710,426
Ensembl chr13:98,615,287...98,708,149
G
Jade2
jade family PHD finger 2
decreases expression
EXP
Cephaloridine results in decreased expression of JADE2 mRNA
CTD
PMID:18500788
NCBI chr10:37,269,132...37,315,638
Ensembl chr10:37,270,183...37,311,625
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Cephaloridine results in increased expression of JUN mRNA
CTD
PMID:18172885
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
decreases expression increases expression
EXP
Cephaloridine results in decreased expression of JUNB mRNA Cephaloridine results in increased expression of JUNB mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr19:26,092,972...26,094,756
Ensembl chr19:26,092,974...26,094,756
G
Kbtbd11
kelch repeat and BTB domain containing 11
decreases expression
EXP
Cephaloridine results in decreased expression of KBTBD11 mRNA
CTD
PMID:18500788
NCBI chr16:79,696,395...79,716,129
Ensembl chr16:79,696,891...79,700,992
G
Kcnh1
potassium voltage-gated channel subfamily H member 1
increases expression
EXP
Cephaloridine results in increased expression of KCNH1 mRNA
CTD
PMID:18500788
NCBI chr13:110,920,712...111,232,291
Ensembl chr13:110,920,737...111,232,269
G
Kcnj15
potassium inwardly-rectifying channel, subfamily J, member 15
decreases expression
EXP
Cephaloridine results in decreased expression of KCNJ15 mRNA
CTD
PMID:18500788
NCBI chr11:35,545,185...35,588,517
Ensembl chr11:35,568,182...35,585,390
G
Kctd1
potassium channel tetramerization domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of KCTD1 mRNA
CTD
PMID:18500788
NCBI chr18:6,374,778...6,474,990
Ensembl chr18:6,374,778...6,474,990
G
Kif18a
kinesin family member 18A
decreases expression
EXP
Cephaloridine results in decreased expression of KIF18A mRNA
CTD
PMID:18500788
NCBI chr 3:100,366,168...100,426,867
Ensembl chr 3:100,366,168...100,427,030
G
Kif2c
kinesin family member 2C
decreases expression
EXP
Cephaloridine results in decreased expression of KIF2C mRNA
CTD
PMID:18500788
NCBI chr 5:136,027,923...136,053,268
Ensembl chr 5:136,027,934...136,053,210
G
Klf7
Kruppel like factor 7
decreases expression
EXP
Cephaloridine results in decreased expression of KLF7 mRNA
CTD
PMID:18500788
NCBI chr 9:70,740,480...70,787,913
Ensembl chr 9:70,740,480...70,787,913
G
Klhl25
kelch-like family member 25
decreases expression
EXP
Cephaloridine results in decreased expression of KLHL25 mRNA
CTD
PMID:18500788
NCBI chr 1:137,333,880...137,359,107
Ensembl chr 1:137,333,881...137,359,072
G
Knstrn
kinetochore-localized astrin/SPAG5 binding protein
decreases expression
EXP
Cephaloridine results in decreased expression of KNSTRN mRNA
CTD
PMID:18500788
NCBI chr 3:110,618,256...110,638,024
Ensembl chr 3:110,618,298...110,638,046
G
Kntc1
kinetochore associated 1
increases expression
EXP
Cephaloridine results in increased expression of KNTC1 mRNA
CTD
PMID:18500788
NCBI chr12:38,200,463...38,274,162
Ensembl chr12:38,200,463...38,274,036
G
Lama2
laminin subunit alpha 2
decreases expression
EXP
Cephaloridine results in decreased expression of LAMA2 mRNA
CTD
PMID:18500788
NCBI chr 1:18,491,264...19,143,486
Ensembl chr 1:18,491,384...19,143,269
G
Lamb3
laminin subunit beta 3
increases expression
EXP
Cephaloridine results in increased expression of LAMB3 mRNA
CTD
PMID:18500788
NCBI chr13:112,031,614...112,073,187
Ensembl chr13:112,031,594...112,073,186
G
Lars1
leucyl-tRNA synthetase 1
decreases expression
EXP
Cephaloridine results in decreased expression of LARS mRNA
CTD
PMID:18500788
NCBI chr18:36,524,013...36,579,471
Ensembl chr18:36,524,007...36,579,403
G
Lcor
ligand dependent nuclear receptor corepressor
decreases expression
EXP
Cephaloridine results in decreased expression of LCOR mRNA
CTD
PMID:18500788
NCBI chr 1:260,775,091...260,839,549
Ensembl chr 1:260,732,485...260,830,854
G
Lect2
leukocyte cell-derived chemotaxin 2
decreases expression
EXP
Cephaloridine results in decreased expression of LECT2 mRNA
CTD
PMID:18500788
NCBI chr17:8,489,261...8,495,483
Ensembl chr17:8,489,266...8,495,496
G
Lgals2
galectin 2
increases expression
EXP
Cephaloridine results in increased expression of LGALS2 mRNA
CTD
PMID:18500788
NCBI chr 7:120,071,122...120,077,612
Ensembl chr 7:120,071,124...120,077,612
G
Lgals3
galectin 3
increases expression
EXP
Cephaloridine results in increased expression of LGALS3 mRNA
CTD
PMID:18500788
NCBI chr15:24,153,602...24,165,537
Ensembl chr15:24,141,651...24,165,537
G
Lhx3
LIM homeobox 3
decreases expression
EXP
Cephaloridine results in decreased expression of LHX3 mRNA
CTD
PMID:18500788
NCBI chr 3:3,653,861...3,662,509
Ensembl chr 3:3,654,755...3,661,810
G
Lig1
DNA ligase 1
increases expression
EXP
Cephaloridine results in increased expression of LIG1 mRNA
CTD
PMID:18500788
NCBI chr 1:75,356,212...75,394,757
Ensembl chr 1:75,356,220...75,394,758
G
Lmnb1
lamin B1
decreases expression
EXP
Cephaloridine results in decreased expression of LMNB1 mRNA
CTD
PMID:18500788
NCBI chr18:51,785,111...51,822,264
Ensembl chr18:51,785,111...51,822,264
G
Lratd1
LRAT domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of LRATD1 mRNA
CTD
PMID:18500788
NCBI chr 6:39,358,285...39,363,458
Ensembl chr 6:39,358,985...39,363,458
G
Lrrn3
leucine rich repeat neuronal 3
decreases expression
EXP
Cephaloridine results in decreased expression of LRRN3 mRNA
CTD
PMID:18500788
NCBI chr 6:61,374,328...61,405,195
Ensembl chr 6:61,374,328...61,405,195
G
Maf
MAF bZIP transcription factor
decreases expression
EXP
Cephaloridine results in decreased expression of MAF mRNA
CTD
PMID:18500788
NCBI chr19:48,179,826...48,200,995
Ensembl chr19:48,194,804...48,196,748
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
increases expression
EXP
Cephaloridine results in increased expression of MAP3K1 mRNA
CTD
PMID:18172885
NCBI chr 2:43,329,516...43,393,203
Ensembl chr 2:43,329,516...43,393,207
G
Map3k12
mitogen activated protein kinase kinase kinase 12
decreases expression
EXP
Cephaloridine results in decreased expression of MAP3K12 mRNA
CTD
PMID:18172885
NCBI chr 7:144,102,275...144,120,306
Ensembl chr 7:144,102,680...144,109,116
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation increases activity
EXP
Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK1 protein] Cephaloridine results in increased activity of MAPK1 protein
CTD
PMID:16154539 PMID:16272694
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
increases activity multiple interactions increases phosphorylation
EXP
Cephaloridine results in increased activity of MAPK3 protein Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK3 protein]
CTD
PMID:16154539 PMID:16272694
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
increases expression
EXP
Cephaloridine results in increased expression of MAPK8IP3 mRNA
CTD
PMID:18500788
NCBI chr10:14,259,394...14,299,276
Ensembl chr10:14,260,787...14,299,167
G
Masp2
mannan-binding lectin serine peptidase 2
increases expression
EXP
Cephaloridine results in increased expression of MASP2 mRNA
CTD
PMID:18500788
NCBI chr 5:165,415,105...165,429,857
Ensembl chr 5:165,415,136...165,430,054
G
Mcm2
minichromosome maintenance complex component 2
increases expression
EXP
Cephaloridine results in increased expression of MCM2 mRNA
CTD
PMID:18500788
NCBI chr 4:120,825,699...120,840,221
Ensembl chr 4:120,825,699...120,840,111
G
Mcm3
minichromosome maintenance complex component 3
increases expression
EXP
Cephaloridine results in increased expression of MCM3 mRNA
CTD
PMID:18500788
NCBI chr 9:26,914,057...26,932,201
Ensembl chr 9:26,914,057...26,932,201
G
Mcm5
minichromosome maintenance complex component 5
increases expression
EXP
Cephaloridine results in increased expression of MCM5 mRNA
CTD
PMID:18500788
NCBI chr19:14,523,482...14,561,281
Ensembl chr19:14,523,554...14,561,278
G
Mcm6
minichromosome maintenance complex component 6
increases expression
EXP
Cephaloridine results in increased expression of MCM6 mRNA
CTD
PMID:18500788
NCBI chr13:45,042,882...45,068,073
Ensembl chr13:45,042,882...45,068,077
G
Mcm7
minichromosome maintenance complex component 7
increases expression
EXP
Cephaloridine results in increased expression of MCM7 mRNA
CTD
PMID:18500788
NCBI chr12:19,306,615...19,313,877
Ensembl chr12:19,306,607...19,314,016
G
Mcm8
minichromosome maintenance 8 homologous recombination repair factor
increases expression
EXP
Cephaloridine results in increased expression of MCM8 mRNA
CTD
PMID:18500788
NCBI chr 3:125,470,499...125,500,795
Ensembl chr 3:125,470,551...125,500,795
G
Mesp1
mesoderm posterior bHLH transcription factor 1
decreases expression
EXP
Cephaloridine results in decreased expression of MESP1 mRNA
CTD
PMID:18500788
NCBI chr 1:141,532,390...141,533,908
Ensembl chr 1:141,532,390...141,533,908
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
EXP
Cephaloridine results in increased expression of MET mRNA
CTD
PMID:18172885
NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665
G
Mgll
monoglyceride lipase
decreases expression
EXP
Cephaloridine results in decreased expression of MGLL mRNA
CTD
PMID:18500788
NCBI chr 4:120,671,436...120,773,458
Ensembl chr 4:120,671,489...120,771,088
G
Mki67
marker of proliferation Ki-67
decreases expression
EXP
Cephaloridine results in decreased expression of MKI67 mRNA
CTD
PMID:18500788
NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
G
Mmp12
matrix metallopeptidase 12
increases expression
EXP
Cephaloridine results in increased expression of MMP12 mRNA
CTD
PMID:18500788
NCBI chr 8:5,594,717...5,616,494
Ensembl chr 8:5,606,592...5,616,493
G
Mmp16
matrix metallopeptidase 16
increases expression
EXP
Cephaloridine results in increased expression of MMP16 mRNA
CTD
PMID:18500788
NCBI chr 5:31,568,344...31,818,368
Ensembl chr 5:31,568,419...31,810,484
G
Mnd1
meiotic nuclear divisions 1
increases expression
EXP
Cephaloridine results in increased expression of MND1 mRNA
CTD
PMID:18500788
NCBI chr 2:183,073,029...183,140,768
Ensembl chr 2:183,073,187...183,128,932
G
Mns1
meiosis-specific nuclear structural 1
decreases expression
EXP
Cephaloridine results in decreased expression of MNS1 mRNA
CTD
PMID:18500788
NCBI chr 8:79,054,240...79,075,119
Ensembl chr 8:79,054,237...79,075,122
G
Mpst
mercaptopyruvate sulfurtransferase
decreases expression
EXP
Cephaloridine results in decreased expression of MPST mRNA
CTD
PMID:18500788
NCBI chr 7:119,626,636...119,631,317
Ensembl chr 7:119,626,637...119,631,425
G
Mpv17l
MPV17 mitochondrial inner membrane protein like
decreases expression
EXP
Cephaloridine results in decreased expression of MPV17L mRNA
CTD
PMID:18500788
NCBI chr10:3,321,488...3,359,219
Ensembl chr10:3,321,476...3,357,470
G
Mrps36
mitochondrial ribosomal protein S36
increases expression
EXP
Cephaloridine results in increased expression of MRPS36 mRNA
CTD
PMID:18500788
NCBI chr 2:30,740,620...30,750,916
Ensembl chr 2:30,739,855...30,748,428
G
Mt1
metallothionein 1
decreases expression
EXP
Cephaloridine results in decreased expression of MT1A mRNA
CTD
PMID:18172885
NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
increases expression
EXP
Cephaloridine results in increased expression of MTHFD1L mRNA
CTD
PMID:18500788
NCBI chr 1:40,529,092...40,719,232
Ensembl chr 1:40,529,045...40,719,391
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
EXP
Cephaloridine results in increased expression of MTHFD2 mRNA
CTD
PMID:18500788
NCBI chr 4:115,004,433...115,015,965
Ensembl chr 4:115,004,448...115,015,965
G
Myom3
myomesin 3
increases expression
EXP
Cephaloridine results in increased expression of MYOM3 mRNA
CTD
PMID:18500788
NCBI chr 5:154,109,293...154,159,943
Ensembl chr 5:154,112,076...154,159,601
G
Ncor2
nuclear receptor co-repressor 2
decreases expression
EXP
Cephaloridine results in decreased expression of NCOR2 mRNA
CTD
PMID:18500788
NCBI chr12:36,871,917...37,033,701
Ensembl chr12:36,871,999...37,033,701
G
Nek6
NIMA-related kinase 6
increases expression
EXP
Cephaloridine results in increased expression of NEK6 mRNA
CTD
PMID:18500788
NCBI chr 3:22,811,927...22,888,598
Ensembl chr 3:22,811,927...22,888,598
G
Nfil3
nuclear factor, interleukin 3 regulated
increases expression
EXP
Cephaloridine results in increased expression of NFIL3 mRNA
CTD
PMID:18500788
NCBI chr17:12,261,102...12,276,316
Ensembl chr17:12,261,102...12,276,315
G
Nfkbia
NFKB inhibitor alpha
decreases expression
EXP
Cephaloridine results in decreased expression of NFKBIA mRNA
CTD
PMID:18172885
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Nfkbiz
NFKB inhibitor zeta
decreases expression
EXP
Cephaloridine results in decreased expression of NFKBIZ mRNA
CTD
PMID:18500788
NCBI chr11:47,243,342...47,271,487
Ensembl chr11:47,243,342...47,271,487
G
Ngfr
nerve growth factor receptor
increases expression
EXP
Cephaloridine results in increased expression of NGFR mRNA
CTD
PMID:18500788
NCBI chr10:83,389,828...83,408,061
Ensembl chr10:83,389,847...83,408,061
G
Nhp2
NHP2 ribonucleoprotein
increases expression
EXP
Cephaloridine results in increased expression of NHP2 mRNA
CTD
PMID:18500788
NCBI chr10:34,975,701...34,979,082
Ensembl chr10:34,975,708...34,979,082
G
Ninj2
ninjurin 2
increases expression
EXP
Cephaloridine results in increased expression of NINJ2 mRNA
CTD
PMID:18500788
NCBI chr 4:152,630,464...152,733,631
Ensembl chr 4:152,630,469...152,733,633
G
Nipsnap3b
nipsnap homolog 3B
increases expression
EXP
Cephaloridine results in increased expression of NIPSNAP3B mRNA
CTD
PMID:18500788
NCBI chr 5:69,833,200...69,849,116
Ensembl chr 5:69,833,225...69,849,112
G
Nme4
NME/NM23 nucleoside diphosphate kinase 4
decreases expression
EXP
Cephaloridine results in decreased expression of NME4 mRNA
CTD
PMID:18500788
NCBI chr10:15,461,567...15,465,422
Ensembl chr10:15,431,638...15,465,413
G
Nop56
NOP56 ribonucleoprotein
increases expression
EXP
Cephaloridine results in increased expression of NOP56 mRNA
CTD
PMID:18500788
NCBI chr 3:122,803,726...122,808,564
Ensembl chr 3:122,803,772...122,808,558
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Cephaloridine results in increased expression of NQO1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
increases expression
EXP
Cephaloridine results in increased expression of NR1D1 mRNA
CTD
PMID:18500788
NCBI chr10:86,683,875...86,690,815
Ensembl chr10:86,683,875...86,690,815
G
Nrm
nurim
increases expression
EXP
Cephaloridine results in increased expression of NRM mRNA
CTD
PMID:18500788
NCBI chr20:3,397,834...3,402,264
Ensembl chr20:3,397,834...3,401,315
G
Nudt11
nudix hydrolase 11
increases expression
EXP
Cephaloridine results in increased expression of NUDT10 mRNA; Cephaloridine results in increased expression of NUDT11 mRNA
CTD
PMID:18500788
NCBI chr X:17,171,510...17,215,108
Ensembl chr X:17,540,458...17,540,952 Ensembl chr X:17,540,458...17,540,952
G
Olr110
olfactory receptor 110
decreases expression
EXP
Cephaloridine results in decreased expression of OLR110 mRNA
CTD
PMID:18500788
NCBI chr 1:168,655,404...168,656,369
Ensembl chr 1:168,655,404...168,656,369
G
Olr1583
olfactory receptor 1583
increases expression
EXP
Cephaloridine results in increased expression of OLR1583 mRNA
CTD
PMID:18500788
NCBI chr13:91,725,324...91,726,265
Ensembl chr13:91,725,324...91,726,265
G
Olr16
olfactory receptor 16
decreases expression
EXP
Cephaloridine results in decreased expression of OLR16 mRNA
CTD
PMID:18500788
NCBI chr 1:149,674,493...149,675,443
Ensembl chr 1:149,674,493...149,675,443
G
Olr1657
olfactory receptor 1657
increases expression
EXP
Cephaloridine results in increased expression of OLR1657 mRNA
CTD
PMID:18500788
G
Olr202
olfactory receptor 202
increases expression
EXP
Cephaloridine results in increased expression of OLR202 mRNA
CTD
PMID:18500788
NCBI chr 1:170,185,494...170,186,462
Ensembl chr 1:170,185,494...170,186,462
G
Olr390
olfactory receptor 390
decreases expression
EXP
Cephaloridine results in decreased expression of OLR390 mRNA
CTD
PMID:18500788
NCBI chr 2:199,528,902...199,529,864
Ensembl chr 2:199,528,902...199,529,864
G
Olr46
olfactory receptor 46
decreases expression
EXP
Cephaloridine results in decreased expression of OLR46 mRNA
CTD
PMID:18500788
NCBI chr 1:167,758,636...167,759,580
Ensembl chr 1:167,758,636...167,759,580
G
Oprl1
opioid related nociceptin receptor 1
increases expression
EXP
Cephaloridine results in increased expression of OPRL1 mRNA
CTD
PMID:18500788
NCBI chr 3:177,223,779...177,231,663
Ensembl chr 3:177,225,737...177,231,663
G
Orc6
origin recognition complex, subunit 6
increases expression
EXP
Cephaloridine results in increased expression of ORC6 mRNA
CTD
PMID:18500788
NCBI chr19:27,457,541...27,464,804
Ensembl chr19:27,457,474...27,464,805
G
Osbpl8
oxysterol binding protein-like 8
decreases expression
EXP
Cephaloridine results in decreased expression of OSBPL8 mRNA
CTD
PMID:18500788
NCBI chr 7:53,878,906...54,030,110
Ensembl chr 7:53,878,610...54,027,892
G
Osmr
oncostatin M receptor
increases expression
EXP
Cephaloridine results in increased expression of OSMR mRNA
CTD
PMID:18500788
NCBI chr 2:56,107,491...56,163,522
Ensembl chr 2:56,110,777...56,151,531
G
Oxgr1
oxoglutarate receptor 1
increases expression
EXP
Cephaloridine results in increased expression of OXGR1 mRNA
CTD
PMID:18500788
NCBI chr15:105,399,596...105,422,559
Ensembl chr15:105,401,695...105,402,708
G
Padi6
peptidyl arginine deiminase 6
increases expression
EXP
Cephaloridine results in increased expression of PADI6 mRNA
CTD
PMID:18500788
NCBI chr 5:159,241,276...159,256,749
Ensembl chr 5:159,241,413...159,256,699
G
Palb2
partner and localizer of BRCA2
increases expression
EXP
Cephaloridine results in increased expression of PALB2 mRNA
CTD
PMID:18500788
NCBI chr 1:192,064,586...192,088,547
Ensembl chr 1:192,064,589...192,088,520
G
Pask
PAS domain containing serine/threonine kinase
increases expression
EXP
Cephaloridine results in increased expression of PASK mRNA
CTD
PMID:18500788
NCBI chr 9:100,450,595...100,479,719
Ensembl chr 9:100,450,586...100,479,868
G
Pbk
PDZ binding kinase
decreases expression
EXP
Cephaloridine results in decreased expression of PBK mRNA
CTD
PMID:18500788
NCBI chr15:42,489,253...42,500,377
Ensembl chr15:42,489,377...42,500,395
G
Pcdh7
protocadherin 7
decreases expression
EXP
Cephaloridine results in decreased expression of PCDH7 mRNA
CTD
PMID:18500788
NCBI chr14:54,649,054...55,081,632
Ensembl chr14:55,072,200...55,081,551
G
Pcdh9
protocadherin 9
decreases expression
EXP
Cephaloridine results in decreased expression of PCDH9 mRNA
CTD
PMID:18500788
NCBI chr15:76,787,108...77,738,668
Ensembl chr15:77,733,402...77,736,892
G
Pck1
phosphoenolpyruvate carboxykinase 1
decreases expression
EXP
Cephaloridine results in decreased expression of PCK1 mRNA
CTD
PMID:18500788
NCBI chr 3:171,213,936...171,219,885
Ensembl chr 3:171,213,936...171,219,871
G
Pclaf
PCNA clamp associated factor
increases expression
EXP
Cephaloridine results in increased expression of PCLAF mRNA
CTD
PMID:18500788
NCBI chr 8:71,514,281...71,526,182
Ensembl chr 8:71,514,281...71,526,182
G
Pcna
proliferating cell nuclear antigen
increases expression
EXP
Cephaloridine results in increased expression of PCNA mRNA
CTD
PMID:18500788
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
G
Pdia4
protein disulfide isomerase family A, member 4
increases expression
EXP
Cephaloridine results in increased expression of PDIA4 mRNA
CTD
PMID:18172885
NCBI chr 4:77,470,636...77,489,535
Ensembl chr 4:77,470,636...77,489,535
G
Pfn3
profilin 3
decreases expression
EXP
Cephaloridine results in decreased expression of PFN3 mRNA
CTD
PMID:18500788
NCBI chr17:9,746,485...9,747,012
Ensembl chr17:9,746,485...9,747,012
G
Pipox
pipecolic acid and sarcosine oxidase
increases expression
EXP
Cephaloridine results in increased expression of PIPOX mRNA
CTD
PMID:18500788
NCBI chr10:64,951,986...64,964,865
Ensembl chr10:64,952,119...64,964,862
G
Pir
pirin
increases expression
EXP
Cephaloridine results in increased expression of PIR mRNA
CTD
PMID:18500788
NCBI chr X:31,852,322...31,968,152
Ensembl chr X:31,852,323...31,968,152
G
Pkhd1
PKHD1 ciliary IPT domain containing fibrocystin/polyductin
decreases expression
EXP
Cephaloridine results in decreased expression of PKHD1 mRNA
CTD
PMID:18500788
NCBI chr 9:26,164,969...26,736,704
G
Pkmyt1
protein kinase, membrane associated tyrosine/threonine 1
increases expression
EXP
Cephaloridine results in increased expression of PKMYT1 mRNA
CTD
PMID:18500788
NCBI chr10:13,061,077...13,072,277
Ensembl chr10:13,061,170...13,073,283
G
Pla1a
phospholipase A1 member A
increases expression
EXP
Cephaloridine results in increased expression of PLA1A mRNA
CTD
PMID:18500788
NCBI chr11:64,882,024...64,919,714
Ensembl chr11:64,882,288...64,919,579
G
Plek2
pleckstrin 2
increases expression
EXP
Cephaloridine results in increased expression of PLEK2 mRNA
CTD
PMID:18500788
NCBI chr 6:102,076,736...102,095,002
Ensembl chr 6:102,075,632...102,095,201
G
Plekha5
pleckstrin homology domain containing A5
decreases expression
EXP
Cephaloridine results in decreased expression of PLEKHA5 mRNA
CTD
PMID:18500788
NCBI chr 4:174,605,462...174,774,692
Ensembl chr 4:174,605,476...174,774,693
G
Plk1
polo-like kinase 1
decreases expression
EXP
Cephaloridine results in decreased expression of PLK1 mRNA
CTD
PMID:18500788
NCBI chr 1:192,115,990...192,125,969
Ensembl chr 1:192,115,966...192,125,989
G
Pola2
DNA polymerase alpha 2, accessory subunit
increases expression
EXP
Cephaloridine results in increased expression of POLA2 mRNA
CTD
PMID:18500788
NCBI chr 1:221,297,417...221,321,601
Ensembl chr 1:221,273,538...221,321,570
G
Pold1
DNA polymerase delta 1, catalytic subunit
increases expression
EXP
Cephaloridine results in increased expression of POLD1 mRNA
CTD
PMID:18500788
NCBI chr 1:100,538,066...100,554,105
Ensembl chr 1:100,537,900...100,554,488
G
Pole
DNA polymerase epsilon, catalytic subunit
increases expression
EXP
Cephaloridine results in increased expression of POLE mRNA
CTD
PMID:18500788
NCBI chr12:52,403,533...52,452,075
Ensembl chr12:52,403,529...52,452,040
G
Ppa1
inorganic pyrophosphatase 1
increases expression
EXP
Cephaloridine results in increased expression of PPA1 mRNA
CTD
PMID:18500788
NCBI chr20:31,265,519...31,292,451
Ensembl chr20:31,265,483...31,310,674
G
Ppm1j
protein phosphatase, Mg2+/Mn2+ dependent, 1J
increases expression
EXP
Cephaloridine results in increased expression of PPM1J mRNA
CTD
PMID:18500788
NCBI chr 2:207,263,307...207,268,601
Ensembl chr 2:207,262,934...207,268,609
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
decreases expression
EXP
Cephaloridine results in decreased expression of PPP1R15A mRNA
CTD
PMID:18500788
NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974
G
Prc1
protein regulator of cytokinesis 1
decreases expression
EXP
Cephaloridine results in decreased expression of PRC1 mRNA
CTD
PMID:18500788
NCBI chr 1:142,087,181...142,108,746
Ensembl chr 1:142,087,208...142,108,746
G
Prim1
DNA primase subunit 1
increases expression
EXP
Cephaloridine results in increased expression of PRIM1 mRNA
CTD
PMID:18500788
NCBI chr 7:2,435,524...2,451,169
Ensembl chr 7:2,435,553...2,451,165
G
Prkar1b
protein kinase cAMP-dependent type I regulatory subunit beta
increases expression
EXP
Cephaloridine results in increased expression of PRKAR1B mRNA
CTD
PMID:18500788
NCBI chr12:17,614,536...17,713,567
Ensembl chr12:17,614,632...17,712,373
G
Prodh2
proline dehydrogenase 2
decreases expression
EXP
Cephaloridine results in decreased expression of PRODH2 mRNA
CTD
PMID:18500788
NCBI chr 1:88,955,125...88,968,501
Ensembl chr 1:88,955,135...88,968,501
G
Prrx1
paired related homeobox 1
decreases expression
EXP
Cephaloridine results in decreased expression of PRRX1 mRNA
CTD
PMID:18500788
NCBI chr13:81,147,038...81,215,559
Ensembl chr13:81,147,348...81,214,546
G
Prss35
serine protease 35
decreases expression
EXP
Cephaloridine results in decreased expression of PRSS35 mRNA
CTD
PMID:18500788
NCBI chr 8:94,423,629...94,440,509
Ensembl chr 8:94,423,808...94,440,503
G
Psmb4
proteasome 20S subunit beta 4
increases expression
EXP
Cephaloridine results in increased expression of PSMB4 mRNA
CTD
PMID:18172885
NCBI chr 2:196,043,546...196,046,320
Ensembl chr 2:196,043,618...196,046,311
G
Ptbp1
polypyrimidine tract binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of PTBP1 mRNA
CTD
PMID:18172885
NCBI chr 7:12,663,965...12,673,723
Ensembl chr 7:12,663,965...12,673,718
G
Ptgr1
prostaglandin reductase 1
increases expression
EXP
Cephaloridine results in increased expression of PTGR1 mRNA
CTD
PMID:18500788
NCBI chr 5:76,110,746...76,129,361
Ensembl chr 5:76,110,738...76,129,441
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
decreases expression
EXP
Cephaloridine results in decreased expression of PTPN11 mRNA
CTD
PMID:18500788
NCBI chr12:40,895,515...40,955,999
Ensembl chr12:40,895,515...40,955,999
G
Ptprb
protein tyrosine phosphatase, receptor type, B
decreases expression
EXP
Cephaloridine results in decreased expression of PTPRB mRNA
CTD
PMID:18500788
NCBI chr 7:59,326,484...59,431,114
Ensembl chr 7:59,326,518...59,425,718
G
Ptprn2
protein tyrosine phosphatase, receptor type N2
increases expression
EXP
Cephaloridine results in increased expression of PTPRN2 mRNA
CTD
PMID:18500788
NCBI chr 6:144,384,773...145,133,042
Ensembl chr 6:144,384,773...145,133,042
G
Ptrh1
peptidyl-tRNA hydrolase 1 homolog
increases expression
EXP
Cephaloridine results in increased expression of PTRH1 mRNA
CTD
PMID:18500788
NCBI chr 3:11,811,303...11,817,007
Ensembl chr 3:11,811,962...11,825,640
G
Pvr
PVR cell adhesion molecule
increases expression
EXP
Cephaloridine results in increased expression of PVR mRNA
CTD
PMID:18500788
NCBI chr 1:80,820,306...80,835,712
Ensembl chr 1:80,820,050...80,835,701
G
Rab11fip3
RAB11 family interacting protein 3
decreases expression
EXP
Cephaloridine results in decreased expression of RAB11FIP3 mRNA
CTD
PMID:18500788
NCBI chr10:15,348,356...15,433,384
Ensembl chr10:15,349,888...15,381,691
G
Rab31
RAB31, member RAS oncogene family
decreases expression
EXP
Cephaloridine results in decreased expression of RAB31 mRNA
CTD
PMID:18500788
NCBI chr 9:113,370,072...113,504,606
Ensembl chr 9:113,370,033...113,504,605
G
Rad18
RAD18 E3 ubiquitin protein ligase
increases expression
EXP
Cephaloridine results in increased expression of RAD18 mRNA
CTD
PMID:18500788
NCBI chr 4:144,537,329...144,620,606
Ensembl chr 4:144,536,729...144,620,731
G
Rb1
RB transcriptional corepressor 1
affects activity
EXP
Cephaloridine affects the activity of RB1 protein
CTD
PMID:18500788
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
G
Rbp2
retinol binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of RBP2 mRNA
CTD
PMID:18500788
NCBI chr 8:106,479,253...106,527,726
Ensembl chr 8:106,503,504...106,527,711
G
Rbsn
rabenosyn, RAB effector
decreases expression
EXP
Cephaloridine results in decreased expression of RBSN mRNA
CTD
PMID:18500788
NCBI chr 4:124,050,559...124,080,919
Ensembl chr 4:124,052,300...124,080,906
G
Rdh16
retinol dehydrogenase 16
decreases expression
EXP
Cephaloridine results in decreased expression of RDH2 mRNA
CTD
PMID:18500788
NCBI chr 7:71,058,150...71,072,685
Ensembl chr 7:70,980,422...71,072,689
G
Recql4
RecQ like helicase 4
increases expression
EXP
Cephaloridine results in increased expression of RECQL4 mRNA
CTD
PMID:18500788
NCBI chr 7:117,765,892...117,773,128
Ensembl chr 7:117,763,783...117,773,134
G
Rela
RELA proto-oncogene, NF-kB subunit
affects activity
EXP
Cephaloridine affects the activity of RELA protein
CTD
PMID:18500788
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Rfc3
replication factor C subunit 3
increases expression
EXP
Cephaloridine results in increased expression of RFC3 mRNA
CTD
PMID:18500788
NCBI chr12:1,460,581...1,471,344
Ensembl chr12:1,460,538...1,471,357
G
Rfc4
replication factor C subunit 4
increases expression
EXP
Cephaloridine results in increased expression of RFC4 mRNA
CTD
PMID:18500788
NCBI chr11:81,358,592...81,373,044
Ensembl chr11:81,358,592...81,373,043
G
RGD1561843
similar to 60S ribosomal protein L23a
increases expression
EXP
Cephaloridine results in increased expression of RGD1561843 mRNA
CTD
PMID:18500788
NCBI chr 1:1,677,753...1,678,254
G
RGD1561897
similar to Serine/threonine-protein kinase Kist (Kinase interacting with stathmin)
increases expression
EXP
Cephaloridine results in increased expression of RGD1561897 mRNA
CTD
PMID:18500788
NCBI chr17:44,418,463...44,420,729
G
RGD1561944
similar to 60S ribosomal protein L32
decreases expression
EXP
Cephaloridine results in decreased expression of RGD1561944 mRNA
CTD
PMID:18500788
NCBI chr 8:91,300,451...91,301,003
G
RGD1562392
similar to Sulfotransferase K1 (rSULT1C2)
decreases expression
EXP
Cephaloridine results in decreased expression of RGD1562392 mRNA
CTD
PMID:18500788
NCBI chr 9:4,241,300...4,623,136
Ensembl chr 9:4,081,457...4,280,794
G
RGD1564040
similar to methylenetetrahydrofolate dehydrogenase (NAD) (EC 1.5.1.15)/methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9) precursor
increases expression
EXP
Cephaloridine results in increased expression of RGD1564040 mRNA
CTD
PMID:18500788
NCBI chr 5:120,869,141...120,870,270
G
RGD1564324
similar to dehydrogenase/reductase member 2
increases expression
EXP
Cephaloridine results in increased expression of RGD1564324 mRNA
CTD
PMID:18500788
NCBI chr15:33,821,095...33,841,257
Ensembl chr15:33,822,730...33,825,620
G
RGD1564606
similar to 60S ribosomal protein L23a
increases expression
EXP
Cephaloridine results in increased expression of RGD1564606 mRNA
CTD
PMID:18500788
NCBI chr 2:38,230,697...38,231,287
Ensembl chr 2:38,230,757...38,231,227
G
RGD1564866
similar to Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing protein)
increases expression
EXP
Cephaloridine results in increased expression of RGD1564866 mRNA
CTD
PMID:18500788
NCBI chr X:115,424,925...115,426,005
G
RGD1564999
similar to isopentenyl-diphosphate delta isomerase 2
decreases expression
EXP
Cephaloridine results in decreased expression of RGD1564999 mRNA
CTD
PMID:18500788
NCBI chr17:57,935,992...57,954,998
G
RGD1565017
similar to RS21-C6 protein
increases expression
EXP
Cephaloridine results in increased expression of RGD1565017 mRNA
CTD
PMID:18500788
NCBI chr16:3,935,374...3,936,145
G
RGD1565166
similar to MGC45438 protein
increases expression
EXP
Cephaloridine results in increased expression of RGD1565166 mRNA
CTD
PMID:18500788
NCBI chr10:10,555,337...10,564,433
Ensembl chr10:10,555,337...10,564,433
G
Rgn
regucalcin
decreases expression
EXP
Cephaloridine results in decreased expression of RGN mRNA
CTD
PMID:8584014 PMID:18500788
NCBI chr X:1,833,484...1,848,904
Ensembl chr X:1,833,492...1,848,904
G
Rgs11
regulator of G-protein signaling 11
increases expression
EXP
Cephaloridine results in increased expression of RGS11 mRNA
CTD
PMID:18500788
G
Rhcg
Rh family, C glycoprotein
increases expression
EXP
Cephaloridine results in increased expression of RHCG mRNA
CTD
PMID:18500788
NCBI chr 1:141,325,854...141,349,881
Ensembl chr 1:141,325,856...141,349,881
G
Rhobtb1
Rho-related BTB domain containing 1
decreases expression
EXP
Cephaloridine results in decreased expression of RHOBTB1 mRNA
CTD
PMID:18500788
NCBI chr20:20,638,579...20,715,437
Ensembl chr20:20,638,579...20,713,128
G
Rhpn2
rhophilin, Rho GTPase binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of RHPN2 mRNA
CTD
PMID:18500788
NCBI chr 1:91,596,344...91,657,395
Ensembl chr 1:91,596,397...91,657,395
G
Rida
reactive intermediate imine deaminase A homolog
decreases expression
EXP
Cephaloridine results in decreased expression of RIDA mRNA
CTD
PMID:18500788
NCBI chr 7:73,256,506...73,270,308
Ensembl chr 7:73,256,508...73,270,308
G
Rnd1
Rho family GTPase 1
increases expression
EXP
Cephaloridine results in increased expression of RND1 mRNA
CTD
PMID:18500788
NCBI chr 7:140,349,138...140,356,209
Ensembl chr 7:140,349,138...140,356,209
G
Rnf227
ring finger protein 227
increases expression
EXP
Cephaloridine results in increased expression of RNF227 mRNA
CTD
PMID:18500788
NCBI chr10:55,940,533...55,941,205
Ensembl chr10:55,940,533...55,941,205
G
Rpl23a
ribosomal protein L23a
increases expression
EXP
Cephaloridine results in increased expression of RPL23A mRNA
CTD
PMID:18500788
NCBI chr10:65,441,295...65,443,981
Ensembl chr10:65,441,295...65,443,981
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP
Cephaloridine results in decreased expression of RRM2 mRNA
CTD
PMID:18500788
NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
decreases expression
EXP
Cephaloridine results in decreased expression of RUNX1T1 mRNA
CTD
PMID:18500788
NCBI chr 5:27,284,921...27,440,802
Ensembl chr 5:27,312,928...27,442,841
G
Rxrg
retinoid X receptor gamma
increases expression
EXP
Cephaloridine results in increased expression of RXRG mRNA
CTD
PMID:18500788
NCBI chr13:85,818,473...85,868,555
Ensembl chr13:85,818,427...85,868,552
G
Scgb3a1
secretoglobin, family 3A, member 1
increases expression
EXP
Cephaloridine results in increased expression of SCGB3A1 mRNA
CTD
PMID:18500788
NCBI chr10:35,133,561...35,134,868
Ensembl chr10:35,133,252...35,135,466
G
Scgb3a2
secretoglobin, family 3A, member 2
increases expression
EXP
Cephaloridine results in increased expression of SCGB3A2 mRNA
CTD
PMID:18500788
NCBI chr18:38,292,822...38,295,744
Ensembl chr18:38,292,701...38,295,831
G
Sct
secretin
increases expression
EXP
Cephaloridine results in increased expression of SCT mRNA
CTD
PMID:18500788
NCBI chr 1:214,264,865...214,277,437
Ensembl chr 1:214,264,754...214,265,668
G
Sectm1b
secreted and transmembrane 1B
increases expression
EXP
Cephaloridine results in increased expression of SECTM1A mRNA
CTD
PMID:18500788
NCBI chr10:110,251,363...110,260,577
Ensembl chr10:110,251,363...110,259,985
G
Selenop
selenoprotein P
decreases expression
EXP
Cephaloridine results in decreased expression of SELENOP mRNA
CTD
PMID:18500788
NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858
G
Sema4c
semaphorin 4C
decreases expression
EXP
Cephaloridine results in decreased expression of SEMA4C mRNA
CTD
PMID:18500788
NCBI chr 9:43,129,413...43,140,442
Ensembl chr 9:43,129,415...43,139,870
G
Septin10
septin 10
decreases expression
EXP
Cephaloridine results in decreased expression of SEPTIN10 mRNA
CTD
PMID:18500788
NCBI chr20:28,722,479...28,814,841
Ensembl chr20:28,722,580...28,814,636
G
Sh2b2
SH2B adaptor protein 2
increases expression
EXP
Cephaloridine results in increased expression of SH2B2 mRNA
CTD
PMID:18500788
NCBI chr12:23,471,477...23,501,043
Ensembl chr12:23,473,270...23,501,036
G
Sh3bp2
SH3-domain binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of SH3BP2 mRNA
CTD
PMID:18500788
NCBI chr14:81,435,445...81,473,013
Ensembl chr14:81,435,449...81,472,952
G
Shroom4
shroom family member 4
decreases expression
EXP
Cephaloridine results in decreased expression of SHROOM4 mRNA
CTD
PMID:18500788
NCBI chr X:16,723,360...16,929,829
Ensembl chr X:16,719,803...16,929,907
G
Ska1
spindle and kinetochore associated complex subunit 1
decreases expression
EXP
Cephaloridine results in decreased expression of SKA1 mRNA
CTD
PMID:18500788
NCBI chr18:70,174,316...70,184,368
Ensembl chr18:70,173,944...70,184,337
G
Slc15a3
solute carrier family 15 member 3
increases expression
EXP
Cephaloridine results in increased expression of SLC15A3 mRNA
CTD
PMID:18500788
NCBI chr 1:226,896,387...226,912,644
Ensembl chr 1:226,897,625...226,912,708
G
Slc16a12
solute carrier family 16, member 12
decreases expression
EXP
Cephaloridine results in decreased expression of SLC16A12 mRNA
CTD
PMID:18500788
NCBI chr 1:252,976,071...253,054,500
Ensembl chr 1:252,976,644...253,000,760
G
Slc16a14
solute carrier family 16, member 14
decreases expression
EXP
Cephaloridine results in decreased expression of SLC16A14 mRNA
CTD
PMID:18500788
NCBI chr 9:92,503,602...92,531,163
Ensembl chr 9:92,503,597...92,530,938
G
Slc1a5
solute carrier family 1 member 5
increases expression
EXP
Cephaloridine results in increased expression of SLC1A5 mRNA
CTD
PMID:18500788
NCBI chr 1:78,710,686...78,724,789
Ensembl chr 1:78,710,539...78,724,794
G
Slc22a23
solute carrier family 22, member 23
decreases expression
EXP
Cephaloridine results in decreased expression of SLC22A23 mRNA
CTD
PMID:18500788
NCBI chr17:31,236,015...31,403,685
Ensembl chr17:31,236,015...31,403,685
G
Slc22a5
solute carrier family 22 member 5
decreases expression
EXP
Cephaloridine results in decreased expression of SLC22A5 mRNA
CTD
PMID:18500788
NCBI chr10:39,201,101...39,228,090
Ensembl chr10:39,201,107...39,323,853
G
Slc22a6
solute carrier family 22 member 6
increases import multiple interactions increases uptake
EXP ISO
SLC22A6 protein results in increased import of Cephaloridine Cephaloridine inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of Cephaloridine
CTD
PMID:10594788 PMID:16098483
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of Cephaloridine Cephaloridine inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Slc35d2
solute carrier family 35 member D2
increases expression
EXP
Cephaloridine results in increased expression of SLC35D2 mRNA
CTD
PMID:18500788
NCBI chr17:1,618,641...1,649,734
Ensembl chr17:1,618,189...1,648,973
G
Slc39a4
solute carrier family 39 member 4
increases expression
EXP
Cephaloridine results in increased expression of SLC39A4 mRNA
CTD
PMID:18500788
NCBI chr 7:117,675,718...117,682,586
Ensembl chr 7:117,675,720...117,680,004
G
Slc41a2
solute carrier family 41 member 2
increases expression
EXP
Cephaloridine results in increased expression of SLC41A2 mRNA
CTD
PMID:18500788
NCBI chr 7:26,522,314...26,607,861
Ensembl chr 7:26,522,314...26,607,861
G
Slc46a3
solute carrier family 46, member 3
increases expression
EXP
Cephaloridine results in increased expression of SLC46A3 mRNA
CTD
PMID:18500788
NCBI chr12:8,725,479...8,741,944
Ensembl chr12:8,725,517...8,741,951
G
Slc4a4
solute carrier family 4 member 4
decreases expression
EXP
Cephaloridine results in decreased expression of SLC4A4 mRNA
CTD
PMID:18500788
NCBI chr14:20,476,258...20,817,042
Ensembl chr14:20,479,323...20,920,286
G
Slc5a3
solute carrier family 5 member 3
increases expression
EXP
Cephaloridine results in increased expression of SLC5A3 mRNA
CTD
PMID:18500788
NCBI chr11:32,229,366...32,231,812
G
Slc7a10
solute carrier family 7 member 10
increases expression
EXP
Cephaloridine results in increased expression of SLC7A10 mRNA
CTD
PMID:18500788
NCBI chr 1:91,432,952...91,448,566
Ensembl chr 1:91,433,030...91,448,564
G
Slc7a5
solute carrier family 7 member 5
increases expression
EXP
Cephaloridine results in increased expression of SLC7A5 mRNA
CTD
PMID:18500788
NCBI chr19:54,693,959...54,722,563
Ensembl chr19:54,693,959...54,722,563
G
Slc7a7
solute carrier family 7 member 7
decreases expression
EXP
Cephaloridine results in decreased expression of SLC7A7 mRNA
CTD
PMID:18500788
NCBI chr15:33,013,346...33,059,733
Ensembl chr15:33,013,504...33,051,129
G
Slc8a1
solute carrier family 8 member A1
decreases expression
EXP
Cephaloridine results in decreased expression of SLC8A1 mRNA
CTD
PMID:18500788
NCBI chr 6:4,244,076...4,564,262
Ensembl chr 6:4,258,991...4,520,604
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
EXP
Cephaloridine results in increased expression of SLPI mRNA
CTD
PMID:18500788
NCBI chr 3:160,799,979...160,802,228
Ensembl chr 3:160,799,981...160,802,433
G
Smyd1
SET and MYND domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of SMYD1 mRNA
CTD
PMID:18500788
NCBI chr 4:99,071,122...99,125,143
Ensembl chr 4:99,074,535...99,125,111
G
Snapc2
small nuclear RNA activating complex, polypeptide 2
increases expression
EXP
Cephaloridine results in increased expression of SNAPC2 mRNA
CTD
PMID:18500788
NCBI chr12:2,537,291...2,540,774
Ensembl chr12:2,537,275...2,540,668
G
Socs3
suppressor of cytokine signaling 3
decreases expression
EXP
Cephaloridine results in decreased expression of SOCS3 mRNA
CTD
PMID:18500788
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
G
Spetex-2B
Spetex-2B protein
increases expression
EXP
Cephaloridine results in increased expression of SPETEX-2B mRNA
CTD
PMID:18500788
NCBI chr 8:1,932,820...1,933,017
G
Spetex-2D
Spetex-2D protein
increases expression
EXP
Cephaloridine results in increased expression of SPETEX-2D mRNA
CTD
PMID:18500788
G
Sphk1
sphingosine kinase 1
increases expression
EXP
Cephaloridine results in increased expression of SPHK1 mRNA
CTD
PMID:18500788
NCBI chr10:105,498,728...105,504,401
Ensembl chr10:105,498,728...105,504,393
G
Spink1
serine peptidase inhibitor, Kazal type 1
decreases expression
EXP
Cephaloridine results in decreased expression of SPINK1 mRNA
CTD
PMID:18500788
NCBI chr18:38,221,919...38,242,092
Ensembl chr18:38,221,681...38,242,119
G
Srpra
SRP receptor subunit alpha
decreases expression
EXP
Cephaloridine results in decreased expression of SRPRA mRNA
CTD
PMID:18500788
NCBI chr 8:36,410,683...36,416,766
Ensembl chr 8:36,410,683...36,416,296
G
Stat3
signal transducer and activator of transcription 3
increases expression
EXP
Cephaloridine results in increased expression of STAT3 mRNA
CTD
PMID:18500788
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Stk35
serine/threonine kinase 35
increases expression
EXP
Cephaloridine results in increased expression of STK35 mRNA
CTD
PMID:18500788
NCBI chr 3:122,307,976...122,340,205
Ensembl chr 3:122,308,025...122,336,468
G
Stra6
signaling receptor and transporter of retinol STRA6
decreases expression
EXP
Cephaloridine results in decreased expression of STRA6 mRNA
CTD
PMID:18500788
NCBI chr 8:62,925,364...62,944,438
Ensembl chr 8:62,925,357...62,944,437
G
Sult1c2a
sulfotransferase family, cytosolic, 1C, member 2a
decreases expression
EXP
Cephaloridine results in decreased expression of SULT1C2 mRNA; Cephaloridine results in decreased expression of SULT1C2A mRNA
CTD
PMID:18500788
NCBI chr 9:4,152,588...4,168,355
Ensembl chr 9:4,152,589...4,168,221
G
Sult4a1
sulfotransferase family 4A, member 1
increases expression
EXP
Cephaloridine results in increased expression of SULT4A1 mRNA
CTD
PMID:18500788
NCBI chr 7:124,958,546...124,982,602
Ensembl chr 7:124,958,546...124,982,566
G
Surf6
surfeit 6
decreases expression
EXP
Cephaloridine results in decreased expression of SURF6 mRNA
CTD
PMID:18500788
NCBI chr 3:5,441,404...5,452,156
Ensembl chr 3:5,441,409...5,452,156
G
Susd2
sushi domain containing 2
decreases expression
EXP
Cephaloridine results in decreased expression of SUSD2 mRNA
CTD
PMID:18500788
NCBI chr20:13,965,098...13,972,547
Ensembl chr20:13,965,121...13,972,547
G
Syne1
spectrin repeat containing nuclear envelope protein 1
decreases expression
EXP
Cephaloridine results in decreased expression of SYNE1 mRNA
CTD
PMID:18500788
NCBI chr 1:41,608,287...41,763,591 NCBI chr 1:41,844,840...42,086,662
Ensembl chr 1:41,608,418...42,077,535
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
EXP
Cephaloridine results in decreased expression of SYNE2 mRNA
CTD
PMID:18500788
NCBI chr 6:98,884,269...99,153,551
G
Sytl5
synaptotagmin-like 5
increases expression
EXP
Cephaloridine results in increased expression of SYTL5 mRNA
CTD
PMID:18500788
NCBI chr X:13,857,669...14,109,592
Ensembl chr X:14,019,961...14,109,568
G
Tac3
tachykinin precursor 3
increases expression
EXP
Cephaloridine results in increased expression of TAC2 mRNA
CTD
PMID:18500788
NCBI chr 7:71,023,976...71,030,582
Ensembl chr 7:71,023,976...71,030,582
G
Tbx3
T-box transcription factor 3
decreases expression
EXP
Cephaloridine results in decreased expression of TBX3 mRNA
CTD
PMID:18500788
NCBI chr12:42,479,518...42,494,588
Ensembl chr12:42,480,560...42,492,526
G
Tcf12
transcription factor 12
decreases expression
EXP
Cephaloridine results in decreased expression of TCF12 mRNA
CTD
PMID:18500788
NCBI chr 8:78,343,634...78,657,738
Ensembl chr 8:78,345,754...78,655,856
G
Tcf19
transcription factor 19
increases expression
EXP
Cephaloridine results in increased expression of TCF19 mRNA
CTD
PMID:18500788
NCBI chr20:3,740,454...3,746,964
Ensembl chr20:3,744,395...3,746,964
G
Tfrc
transferrin receptor
increases expression
EXP
Cephaloridine results in increased expression of TFRC mRNA
CTD
PMID:18500788
NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
increases expression
EXP
Cephaloridine results in increased expression of TICRR mRNA
CTD
PMID:18500788
NCBI chr 1:141,391,738...141,433,615
Ensembl chr 1:141,391,262...141,433,109
G
Timeless
timeless circadian regulator
increases expression
EXP
Cephaloridine results in increased expression of TIMELESS mRNA
CTD
PMID:18500788
NCBI chr 7:2,643,288...2,667,329
Ensembl chr 7:2,643,288...2,667,628
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
EXP
Cephaloridine results in increased expression of TIMP1 mRNA
CTD
PMID:18500788
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
G
Tlr2
toll-like receptor 2
increases expression
EXP
Cephaloridine results in increased expression of TLR2 mRNA
CTD
PMID:18500788
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
G
Tmem163
transmembrane protein 163
increases expression
EXP
Cephaloridine results in increased expression of TMEM163 mRNA
CTD
PMID:18500788
NCBI chr13:44,166,306...44,345,735
Ensembl chr13:44,166,306...44,345,735
G
Tmem252
transmembrane protein 252
decreases expression
EXP
Cephaloridine results in decreased expression of TMEM252 mRNA
CTD
PMID:18500788
NCBI chr 1:242,572,558...242,577,817
Ensembl chr 1:242,572,533...242,577,817
G
Tmem270
transmembrane protein 270
increases expression
EXP
Cephaloridine results in increased expression of TMEM270 mRNA
CTD
PMID:18500788
NCBI chr12:24,803,204...24,808,287
Ensembl chr12:24,803,686...24,808,288
G
Tmem63c
transmembrane protein 63c
increases expression
EXP
Cephaloridine results in increased expression of TMEM63C mRNA
CTD
PMID:18500788
NCBI chr 6:111,044,099...111,120,659
Ensembl chr 6:111,049,559...111,120,799
G
Tmem86a
transmembrane protein 86A
decreases expression
EXP
Cephaloridine results in decreased expression of TMEM86A mRNA
CTD
PMID:18500788
NCBI chr 1:103,173,032...103,177,382
Ensembl chr 1:103,172,987...103,177,417
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
EXP
Cephaloridine results in increased expression of TNFRSF12A mRNA
CTD
PMID:18500788
NCBI chr10:12,995,904...12,997,930
Ensembl chr10:12,995,904...12,997,930
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
EXP
Cephaloridine results in increased expression of TNFRSF1A mRNA
CTD
PMID:18500788
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
G
Tns1
tensin 1
decreases expression
EXP
Cephaloridine results in decreased expression of TNS1 mRNA
CTD
PMID:18500788
NCBI chr 9:81,190,192...81,401,020
Ensembl chr 9:81,194,119...81,400,987
G
Tns4
tensin 4
increases expression
EXP
Cephaloridine results in increased expression of TNS4 mRNA
CTD
PMID:18500788
NCBI chr10:86,977,504...87,001,256
Ensembl chr10:86,977,505...87,001,256
G
Tonsl
tonsoku-like, DNA repair protein
increases expression
EXP
Cephaloridine results in increased expression of TONSL mRNA
CTD
PMID:18500788
NCBI chr 7:117,688,397...117,703,139
Ensembl chr 7:117,688,397...117,703,094
G
Top2a
DNA topoisomerase II alpha
decreases expression
EXP
Cephaloridine results in decreased expression of TOP2A mRNA
CTD
PMID:18500788
NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
G
Tph1
tryptophan hydroxylase 1
increases expression
EXP
Cephaloridine results in increased expression of TPH1 mRNA
CTD
PMID:18500788
NCBI chr 1:102,669,868...102,699,442
Ensembl chr 1:102,669,868...102,699,442
G
Trib3
tribbles pseudokinase 3
increases expression
EXP
Cephaloridine results in increased expression of TRIB3 mRNA
CTD
PMID:18500788
NCBI chr 3:147,814,056...147,819,650
Ensembl chr 3:147,813,473...147,819,571
G
Tril
TLR4 interactor with leucine-rich repeats
decreases expression
EXP
Cephaloridine results in decreased expression of TRIL mRNA
CTD
PMID:18500788
NCBI chr 4:83,967,695...83,972,540
Ensembl chr 4:83,967,696...83,972,540
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
increases expression
EXP
Cephaloridine results in increased expression of TRPC6 mRNA
CTD
PMID:18500788
NCBI chr 8:6,811,543...6,917,534
Ensembl chr 8:6,811,543...6,917,535
G
Ttc39a
tetratricopeptide repeat domain 39A
increases expression
EXP
Cephaloridine results in increased expression of TTC39A mRNA
CTD
PMID:18500788
NCBI chr 5:129,024,505...129,083,226
Ensembl chr 5:129,043,675...129,082,442 Ensembl chr 5:129,043,675...129,082,442
G
Ttk
Ttk protein kinase
decreases expression
EXP
Cephaloridine results in decreased expression of TTK mRNA
CTD
PMID:18500788
NCBI chr 8:91,368,065...91,405,995
Ensembl chr 8:91,368,111...91,405,993
G
Ttll2
tubulin tyrosine ligase like 2
increases expression
EXP
Cephaloridine results in increased expression of TTLL2 mRNA
CTD
PMID:18500788
NCBI chr 1:53,561,142...53,570,118
Ensembl chr 1:53,561,218...53,563,032
G
Tubb3
tubulin, beta 3 class III
increases expression
EXP
Cephaloridine results in increased expression of TUBB3 mRNA
CTD
PMID:18500788
NCBI chr19:56,220,759...56,229,813
Ensembl chr19:56,220,755...56,229,813
G
Tubb6
tubulin, beta 6 class V
increases expression
EXP
Cephaloridine results in increased expression of TUBB6 mRNA
CTD
PMID:18500788
NCBI chr18:63,130,542...63,140,181
Ensembl chr18:63,130,542...63,140,181
G
Tyms
thymidylate synthetase
increases expression
EXP
Cephaloridine results in increased expression of TYMS mRNA
CTD
PMID:18500788
NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564
G
Ubd
ubiquitin D
increases expression
EXP
Cephaloridine results in increased expression of UBD mRNA
CTD
PMID:18500788
NCBI chr20:1,876,175...1,878,126
Ensembl chr20:1,876,173...1,897,814
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
EXP
Cephaloridine results in decreased expression of UBE2C mRNA
CTD
PMID:18500788
NCBI chr 3:161,236,971...161,239,371
Ensembl chr 3:161,236,898...161,241,159
G
Ube2l6
ubiquitin-conjugating enzyme E2L 6
increases expression
EXP
Cephaloridine results in increased expression of UBE2L6 mRNA
CTD
PMID:18500788
NCBI chr 3:72,191,533...72,206,190
Ensembl chr 3:72,191,533...72,206,188
G
Ubl7
ubiquitin-like 7
increases expression
EXP
Cephaloridine results in increased expression of UBL7 mRNA
CTD
PMID:18500788
NCBI chr 8:62,696,557...62,715,694
Ensembl chr 8:62,696,720...62,714,017
G
Uchl1
ubiquitin C-terminal hydrolase L1
increases expression
EXP
Cephaloridine results in increased expression of UCHL1 mRNA
CTD
PMID:18500788
NCBI chr14:43,133,224...43,143,942
Ensembl chr14:43,133,218...43,143,973
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases expression
EXP
Cephaloridine results in increased expression of UGT1A2 mRNA
CTD
PMID:18500788
NCBI chr 9:95,285,592...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
increases expression
EXP
Cephaloridine results in increased expression of UGT1A6 mRNA
CTD
PMID:18500788
NCBI chr 9:95,241,609...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
increases expression
EXP
Cephaloridine results in increased expression of UGT2B7 mRNA
CTD
PMID:18500788
NCBI chr14:22,597,103...22,619,968
G
Uhmk1
U2AF homology motif kinase 1
increases expression
EXP
Cephaloridine results in increased expression of UHMK1 mRNA
CTD
PMID:18500788
NCBI chr13:88,521,625...88,536,728
Ensembl chr13:88,521,625...88,536,728
G
Upp1
uridine phosphorylase 1
increases expression
EXP
Cephaloridine results in increased expression of UPP1 mRNA
CTD
PMID:18500788
NCBI chr14:89,314,234...89,334,060
Ensembl chr14:89,314,176...89,334,276
G
Usp24
ubiquitin specific peptidase 24
decreases expression
EXP
Cephaloridine results in decreased expression of USP24 mRNA
CTD
PMID:18500788
NCBI chr 5:125,896,725...126,030,411
Ensembl chr 5:125,896,725...126,030,401
G
Vcam1
vascular cell adhesion molecule 1
increases expression
EXP
Cephaloridine results in increased expression of VCAM1 mRNA
CTD
PMID:18500788
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
G
Vpreb3
V-set pre-B cell surrogate light chain 3
increases expression
EXP
Cephaloridine results in increased expression of VPREB3 mRNA
CTD
PMID:18500788
NCBI chr20:13,656,683...13,661,542
Ensembl chr20:13,656,825...13,657,943
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of WDHD1 mRNA
CTD
PMID:18500788
NCBI chr15:24,021,674...24,056,073
Ensembl chr15:24,021,674...24,056,073
G
Zc3h13
zinc finger CCCH type containing 13
decreases expression
EXP
Cephaloridine results in decreased expression of ZC3H13 mRNA
CTD
PMID:18500788
NCBI chr15:57,340,522...57,405,287
Ensembl chr15:57,340,579...57,405,287
G
Zdhhc18
zinc finger DHHC-type palmitoyltransferase 18
decreases expression
EXP
Cephaloridine results in decreased expression of ZDHHC18 mRNA
CTD
PMID:18500788
NCBI chr 5:151,829,795...151,856,256
Ensembl chr 5:151,831,527...151,856,256
G
Zfand2a
zinc finger AN1-type containing 2A
decreases expression
EXP
Cephaloridine results in decreased expression of ZFAND2A mRNA
CTD
PMID:18500788
NCBI chr12:17,252,093...17,263,477
Ensembl chr12:17,252,093...17,263,477
G
Zfp367
zinc finger protein 367
increases expression
EXP
Cephaloridine results in increased expression of ZFP367 mRNA
CTD
PMID:18500788
NCBI chr17:1,652,892...1,672,021
Ensembl chr17:1,652,895...1,672,021
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCB11 mRNA
CTD
PMID:24657338
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC2 mRNA
CTD
PMID:24657338
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC3 mRNA
CTD
PMID:24657338
NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Cephalothin results in increased expression of BAX protein
CTD
PMID:15012731
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Casp3
caspase 3
multiple interactions
ISO
Cephalothin results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:15012731
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in decreased expression of CYP8B1 mRNA
CTD
PMID:24657338
NCBI chr 8:130,548,418...130,550,388
Ensembl chr 8:130,548,418...130,550,388
G
Fgf19
fibroblast growth factor 19
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA
CTD
PMID:24657338
NCBI chr 1:218,058,405...218,061,693
Ensembl chr 1:218,058,405...218,061,693
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr14:86,345,946...86,560,694
Ensembl chr14:86,345,953...86,560,694
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr13:53,750,470...53,870,288
Ensembl chr13:53,750,473...53,870,428
G
Slc10a1
solute carrier family 10 member 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr 6:104,617,730...104,631,355
Ensembl chr 6:104,617,730...104,631,355
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
EXP
Cephalothin binds to and results in decreased activity of SLC25A20 protein; Cephalothin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 8:117,455,308...117,476,762
Ensembl chr 8:117,455,262...117,476,734
G
Slc51b
solute carrier family 51 subunit beta
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA
CTD
PMID:24657338
NCBI chr 8:70,930,196...70,938,559
Ensembl chr 8:70,930,347...70,932,986
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA
CTD
PMID:24657338
NCBI chr 4:175,814,118...175,881,775
Ensembl chr 4:175,814,118...175,881,768
G
Tp53
tumor protein p53
increases expression
ISO
Cephalothin results in increased expression of TP53 protein
CTD
PMID:15012731
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Vdr
vitamin D receptor
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA
CTD
PMID:24657338
NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Cefazolin results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
G
Gsr
glutathione-disulfide reductase
multiple interactions increases expression
ISO
Cefazolin results in increased expression of and results in decreased activity of GSR protein Cefazolin results in increased expression of GSR mRNA
CTD
PMID:32196862
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
G
RT1-DOa
RT1 class II, locus DOa
affects expression
ISO
Cefazolin affects the expression of HLA-DOA mRNA
CTD
PMID:25811541
NCBI chr20:3,889,106...3,892,360
Ensembl chr20:3,889,370...3,892,449
G
Slc22a8
solute carrier family 22 member 8
increases uptake
ISO
SLC22A8 protein results in increased uptake of Cefazolin
CTD
PMID:16098483
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
EXP
Cefazolin binds to and results in decreased activity of SLC25A20 protein; Cefazolin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 8:117,455,308...117,476,762
Ensembl chr 8:117,455,262...117,476,734
G
Slc22a6
solute carrier family 22 member 6
multiple interactions increases uptake
ISO
cefdinir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of cefdinir
CTD
PMID:16098483
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc22a8
solute carrier family 22 member 8
multiple interactions increases uptake
ISO
cefdinir inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] SLC22A8 protein results in increased uptake of cefdinir
CTD
PMID:16098483
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Arhgap45
Rho GTPase activating protein 45
affects expression
ISO
cefepime affects the expression of ARHGAP45 mRNA
CTD
PMID:25811541
NCBI chr 7:12,541,032...12,741,314
Ensembl chr 7:12,541,061...12,741,296
G
Cat
catalase
multiple interactions
ISO
cefepime inhibits the reaction [Amikacin results in decreased activity of CAT protein]
CTD
PMID:18781908
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
cefepime results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
cefepime results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 5:165,966,128...165,982,327
G
RT1-Db1
RT1 class II, locus Db1
affects expression
ISO
cefepime affects the expression of HLA-DRB1 mRNA
CTD
PMID:25811541
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
G
Rab8a
RAB8A, member RAS oncogene family
multiple interactions increases uptake
ISO
[RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime RAB8A protein results in increased uptake of Cefixime
CTD
PMID:19074526
NCBI chr16:19,355,047...19,376,776
Ensembl chr16:19,355,048...19,376,776
G
Slc15a1
solute carrier family 15 member 1
multiple interactions increases uptake
ISO
[RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime SLC15A1 protein results in increased uptake of Cefixime
CTD
PMID:19074526
NCBI chr15:106,800,081...106,844,668
Ensembl chr15:106,800,081...106,844,426
G
Abcc4
ATP binding cassette subfamily C member 4
increases transport
ISO
ABCC4 protein results in increased transport of Cefmetazole
CTD
PMID:17939016
NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
EXP
Cefonicid binds to and results in decreased activity of SLC25A20 protein; Cefonicid inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 8:117,455,308...117,476,762
Ensembl chr 8:117,455,262...117,476,734
G
Slc22a7
solute carrier family 22 member 7
multiple interactions
ISO
Cefoperazone inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates]
CTD
PMID:12065749
NCBI chr 9:16,925,321...16,931,119
Ensembl chr 9:16,924,520...16,931,766
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
ISO
cefoselis inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of cefoselis cefoselis inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Cefotaxime results in increased expression of BAX protein
CTD
PMID:15012731
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Il10
interleukin 10
multiple interactions
ISO
Cefotaxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:16939481
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
Cefotaxime results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 5:165,966,128...165,982,327
G
RT1-CE5
RT1 class I, locus CE5
affects expression
ISO
Cefotaxime affects the expression of HLA-F mRNA
CTD
PMID:25811541
NCBI chr20:4,892,702...4,896,993
Ensembl chr20:4,892,702...4,896,991
G
Tp53
tumor protein p53
increases expression
ISO
Cefotaxime results in increased expression of TP53 protein
CTD
PMID:15012731
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
ISO
Cefotiam inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of Cefotiam Cefotiam inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
LOC100364500
RT1 class I, locus CE11-like
affects expression
ISO
Cefoxitin affects the expression of HLA-A mRNA
CTD
PMID:25811541
NCBI chr20:2,704,153...2,707,111
Ensembl chr20:2,704,148...2,707,120
G
RT1-Ha
RT1 class II, locus Ha
affects expression
ISO
Cefoxitin affects the expression of HLA-DPA1 mRNA
CTD
PMID:25811541
NCBI chr20:3,875,478...3,885,140
Ensembl chr20:3,875,706...3,881,461
G
Prl
prolactin
increases expression
ISO
cefpodoxime results in increased expression of PRL protein
CTD
PMID:20083845
NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
G
Abcc4
ATP binding cassette subfamily C member 4
increases transport
ISO
ABCC4 protein results in increased transport of Ceftazidime
CTD
PMID:17939016
NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Ceftazidime results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
G
Il10
interleukin 10
multiple interactions
ISO
Ceftazidime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:16939481
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Slc15a1
solute carrier family 15 member 1
multiple interactions
ISO
[Zinc results in decreased activity of SLC15A1 protein] which results in decreased uptake of ceftibuten
CTD
PMID:14567632
NCBI chr15:106,800,081...106,844,668
Ensembl chr15:106,800,081...106,844,426
G
Slc22a6
solute carrier family 22 member 6
increases uptake multiple interactions
ISO
SLC22A6 protein results in increased uptake of ceftibuten ceftibuten inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of ceftibuten ceftibuten inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Ceftizoxime results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
G
Slc22a6
solute carrier family 22 member 6
multiple interactions increases uptake
ISO
Ceftizoxime inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of Ceftizoxime
CTD
PMID:16098483
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of Ceftizoxime Ceftizoxime inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Ace2
angiotensin I converting enzyme 2
decreases expression
EXP
Ceftriaxone results in decreased expression of ACE2 mRNA
CTD
PMID:29745864
NCBI chr X:32,050,734...32,095,860
Ensembl chr X:32,049,931...32,096,016
G
Actb
actin, beta
increases expression
EXP
Ceftriaxone results in increased expression of ACTB mRNA
CTD
PMID:29745864
NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
G
Bace1
beta-secretase 1
decreases expression
EXP
Ceftriaxone results in decreased expression of BACE1 mRNA
CTD
PMID:29745864
NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361
G
Cat
catalase
decreases expression multiple interactions
ISO EXP
Ceftriaxone results in decreased expression of CAT protein Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]]
CTD
PMID:19442074 PMID:25053526
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Ceftriaxone results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
G
Ece1
endothelin converting enzyme 1
increases expression
EXP
Ceftriaxone results in increased expression of ECE1 mRNA
CTD
PMID:29745864
NCBI chr 5:156,215,469...156,318,652
Ensembl chr 5:156,215,417...156,318,671
G
Epo
erythropoietin
increases expression
EXP
Ceftriaxone results in increased expression of EPO mRNA
CTD
PMID:29745864
NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266
G
Ide
insulin degrading enzyme
increases expression
EXP
Ceftriaxone results in increased expression of IDE mRNA
CTD
PMID:29745864
NCBI chr 1:255,914,465...256,014,168
Ensembl chr 1:255,914,447...256,013,495
G
Il1b
interleukin 1 beta
multiple interactions
EXP
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]]
CTD
PMID:25053526
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Mme
membrane metallo-endopeptidase
increases expression
EXP
Ceftriaxone results in increased expression of MME mRNA
CTD
PMID:29745864
NCBI chr 2:153,799,203...153,880,910
Ensembl chr 2:153,803,349...153,880,738
G
Slc1a2
solute carrier family 1 member 2
multiple interactions increases expression
EXP
Ceftriaxone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]; Ceftriaxone promotes the reaction [Kainic Acid results in increased expression of SLC1A2 protein] Ceftriaxone results in increased expression of SLC1A2 protein
CTD
PMID:19625514 PMID:19717140 PMID:28257918 PMID:29045497
NCBI chr 3:92,518,679...92,665,731
Ensembl chr 3:92,640,752...92,665,644
G
Slc7a11
solute carrier family 7 member 11
multiple interactions
EXP
Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein]
CTD
PMID:19717140
NCBI chr 2:139,453,774...139,528,479
Ensembl chr 2:139,453,774...139,528,162
G
Tnf
tumor necrosis factor
multiple interactions
EXP
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]]
CTD
PMID:25053526
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Cat
catalase
decreases activity
EXP
Cefuroxime results in decreased activity of CAT protein
CTD
PMID:30797828
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Il10
interleukin 10
multiple interactions
ISO
Cefuroxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:16939481
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Nfe2l2
nuclear factor, erythroid 2-like 2
decreases activity
ISO
Cefuroxime results in decreased activity of NFE2L2 protein
CTD
PMID:30203046
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases activity
ISO
Cefuroxime results in decreased activity of NR1I3 protein
CTD
PMID:30203046
NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
G
Ppara
peroxisome proliferator activated receptor alpha
decreases activity
ISO
Cefuroxime results in decreased activity of PPARA protein
CTD
PMID:30203046
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
G
RT1-Bb
RT1 class II, locus Bb
affects expression
ISO
Cefuroxime affects the expression of HLA-DQB1 mRNA
CTD
PMID:25811541
NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711
G
RT1-S3
RT1 class Ib, locus S3
affects expression
ISO
Cefuroxime affects the expression of HLA-E mRNA
CTD
PMID:25811541
NCBI chr20:3,176,124...3,180,825
Ensembl chr20:3,176,107...3,179,818
G
RT1-Ha
RT1 class II, locus Ha
affects expression
ISO
Cephalexin affects the expression of HLA-DPA1 mRNA
CTD
PMID:25811541
NCBI chr20:3,875,478...3,885,140
Ensembl chr20:3,875,706...3,881,461
G
Slc15a1
solute carrier family 15 member 1
increases transport
EXP
SLC15A1 protein results in increased transport of Cephalexin
CTD
PMID:19881305
NCBI chr15:106,800,081...106,844,668
Ensembl chr15:106,800,081...106,844,426
G
Abcc4
ATP binding cassette subfamily C member 4
increases transport
ISO
ABCC4 protein results in increased transport of cephalosporin C
CTD
PMID:17939016
NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
G
Slc15a1
solute carrier family 15 member 1
multiple interactions
ISO
[Zinc results in decreased activity of SLC15A1 protein] which results in decreased uptake of Cephradine
CTD
PMID:14567632
NCBI chr15:106,800,081...106,844,668
Ensembl chr15:106,800,081...106,844,426
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19841
role
19792
application
19465
pharmaceutical
19338
drug
19338
drug allergen
9926
cephalosporin
545
(6R)-7-[(2-amino-1-oxo-2-phenylethyl)amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
0
(6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-8-oxo-3-[(2H-triazol-4-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid propane-1,2-diol
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-(2-carboxypropan-2-yloxyimino)-1-oxoethyl]amino]-8-oxo-3-(1-pyridin-1-iumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-[oxo(propan-2-yloxy)methoxy]ethyl ester
0
(6R,7R)-7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7S)-3-(acetyloxymethyl)-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7S)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[[(2R)-1-oxo-2-phenyl-2-sulfoethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7S)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7S)-7-[[2-(2-amino-4-thiazolyl)-1-oxoethyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7S)-7-[[2-[2-(aminomethyl)phenyl]-1-oxoethyl]amino]-3-[[[1-(carboxymethyl)-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(7R)-7-(4-carboxybutanamido)cephalosporanic acid
0
(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanic acid
0
(7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
3-(acetyloxymethyl)-7-[[3-(4-chloro-3,5-dimethyl-1-pyrazolyl)-2-methyl-1-oxopropyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
3-(carbamoyloxymethyl)cephalosporin +
7
3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
3-hydroxymethylcephalosporin +
0
4-\{((R)-2-Carboxy-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-en-7-ylcarbamoyl)-[(Z)-methoxyimino]-methyl\}-thiazol-2-yl-ammonium +
0
7-[[2-(4-chloro-3,5-dimethyl-1-pyrazolyl)-1-oxoethyl]amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
7-[[2-(4-chloro-3-methyl-1-pyrazolyl)-1-oxopropyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
7-[[2-[5-cyclopropyl-3-(difluoromethyl)-1-pyrazolyl]-1-oxoethyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-8-oxo-3-prop-1-enyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
7beta-aminodeacetoxycephalosporanic acid
0
Cefazolin sodium hydrate
0
Cefodizime sodium
0
Ceftriaxone disodium salt hemiheptahydrate
0
Cefuroxime axetil
0
LSM-5500
0
LSM-5644
0
LSM-5686
0
O-formylcefamandole
0
cefacetrile
0
cefaclor
4
cefadroxil +
1
cefaloglycin
0
cefaloridine
493
cefalotin +
15
cefamandole +
0
cefathiamidine
0
cefatrizine
0
cefazedone
0
cefazolin
5
cefbuperazone
0
cefcapene
0
cefclidin
0
cefdaloxime
0
cefdinir
2
cefditoren +
0
cefepime
5
cefepime hydrochloride
0
cefepime(1+) +
0
cefetamet
0
cefiderocol
0
cefixime
2
cefluprenam
0
cefmenoxime +
0
cefmetazole
1
cefodizime
0
cefonicid
1
cefoperazone
1
ceforanide
0
cefoselis +
2
cefotaxime
5
cefotiam +
2
cefoxitin
2
cefozopran
0
cefpiramide
0
cefpirome +
0
cefpodoxime +
1
cefpodoxime proxetil
0
cefprozil
0
cefroxadine
0
cefsulodin
0
ceftaroline +
0
ceftaroline fosamil +
0
ceftazidime +
3
cefteram
0
ceftezole
0
ceftibuten +
3
ceftiolene
0
ceftizoxime
3
ceftobiprole
0
ceftobiprole medocaril
0
ceftolozane
0
ceftriaxone
13
cefuroxime pivoxetil
0
cefuzonam
0
cephalexin +
2
cephalosporanic acid +
14
cephalosporin C +
1
cephapirin
0
cephapirin sodium
0
cephradine
1
deacetoxycephalosporin C
0
moxalactam
0
Path 2
CHEBI ontology
19841
subatomic particle
19839
composite particle
19839
hadron
19839
baryon
19839
nucleon
19839
atomic nucleus
19839
atom
19839
main group element atom
19732
p-block element atom
19732
carbon group element atom
19636
carbon atom
19625
organic molecular entity
19625
organic group
18537
organic divalent group
18528
organodiyl group
18528
carbonyl group
18436
carbonyl compound
18436
carboxylic acid
18113
carboacyl group
17377
univalent carboacyl group
17377
carbamoyl group
17164
carboxamide
17164
lactam
8034
beta-lactam
793
beta-lactam antibiotic
781
cephem
546
cephalosporin
545
(6R)-7-[(2-amino-1-oxo-2-phenylethyl)amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
0
(6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-8-oxo-3-[(2H-triazol-4-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid propane-1,2-diol
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-(2-carboxypropan-2-yloxyimino)-1-oxoethyl]amino]-8-oxo-3-(1-pyridin-1-iumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-[oxo(propan-2-yloxy)methoxy]ethyl ester
0
(6R,7R)-7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7S)-3-(acetyloxymethyl)-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7S)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[[(2R)-1-oxo-2-phenyl-2-sulfoethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7S)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7S)-7-[[2-(2-amino-4-thiazolyl)-1-oxoethyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(6R,7S)-7-[[2-[2-(aminomethyl)phenyl]-1-oxoethyl]amino]-3-[[[1-(carboxymethyl)-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(7R)-7-(4-carboxybutanamido)cephalosporanic acid
0
(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanic acid
0
(7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
3-(acetyloxymethyl)-7-[[3-(4-chloro-3,5-dimethyl-1-pyrazolyl)-2-methyl-1-oxopropyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
3-(carbamoyloxymethyl)cephalosporin +
7
3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
3-hydroxymethylcephalosporin +
0
4-\{((R)-2-Carboxy-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-en-7-ylcarbamoyl)-[(Z)-methoxyimino]-methyl\}-thiazol-2-yl-ammonium +
0
7-[[2-(4-chloro-3,5-dimethyl-1-pyrazolyl)-1-oxoethyl]amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
7-[[2-(4-chloro-3-methyl-1-pyrazolyl)-1-oxopropyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
7-[[2-[5-cyclopropyl-3-(difluoromethyl)-1-pyrazolyl]-1-oxoethyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-8-oxo-3-prop-1-enyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
7beta-aminodeacetoxycephalosporanic acid
0
Cefazolin sodium hydrate
0
Cefodizime sodium
0
Ceftriaxone disodium salt hemiheptahydrate
0
Cefuroxime axetil
0
LSM-5500
0
LSM-5644
0
LSM-5686
0
O-formylcefamandole
0
cefacetrile
0
cefaclor
4
cefadroxil +
1
cefaloglycin
0
cefaloridine
493
cefalotin +
15
cefamandole +
0
cefathiamidine
0
cefatrizine
0
cefazedone
0
cefazolin
5
cefbuperazone
0
cefcapene
0
cefclidin
0
cefdaloxime
0
cefdinir
2
cefditoren +
0
cefepime
5
cefepime hydrochloride
0
cefepime(1+) +
0
cefetamet
0
cefiderocol
0
cefixime
2
cefluprenam
0
cefmenoxime +
0
cefmetazole
1
cefodizime
0
cefonicid
1
cefoperazone
1
ceforanide
0
cefoselis +
2
cefotaxime
5
cefotiam +
2
cefoxitin
2
cefozopran
0
cefpiramide
0
cefpirome +
0
cefpodoxime +
1
cefpodoxime proxetil
0
cefprozil
0
cefroxadine
0
cefsulodin
0
ceftaroline +
0
ceftaroline fosamil +
0
ceftazidime +
3
cefteram
0
ceftezole
0
ceftibuten +
3
ceftiolene
0
ceftizoxime
3
ceftobiprole
0
ceftobiprole medocaril
0
ceftolozane
0
ceftriaxone
13
cefuroxime pivoxetil
0
cefuzonam
0
cephalexin +
2
cephalosporanic acid +
14
cephalosporin C +
1
cephapirin
0
cephapirin sodium
0
cephradine
1
deacetoxycephalosporin C
0
moxalactam
0